Red blood cell count | White blood cell count,Red blood cell count | Hematocrit,Red blood cell count | globulin,Red blood cell count | Mean hemoglobin concentration,Red blood cell count | Monocytes (#),Red blood cell count | Lactate dehydrogenase,Red blood cell count | Urea,Red blood cell count | Lymphocyte (#),Red blood cell count | Gamma-glutamyl transpeptidase,Red blood cell count | Eosinophil (#),Red blood cell count | Creatinine,Red blood cell count | Neutrophils (#),Red blood cell count | Direct bilirubin,Red blood cell count | Bicarbonate,Red blood cell count | Uric acid,Red blood cell count | Aspartate aminotransferase,Red blood cell count | Average RBC volume,Red blood cell count | Total cholesterol,Red blood cell count | Lymphocytes (%),Red blood cell count | Platelet count,Red blood cell count | Eosinophils (%),Red blood cell count | albumin,Red blood cell count | Basophil (%),Red blood cell count | eGFR (based on CKD-EPI equation),Red blood cell count | Total bilirubin,Red blood cell count | Alkaline phosphatase,Red blood cell count | Alanine aminotransferase,Red blood cell count | Hemoglobin,Red blood cell count | Mean hemoglobin content,Red blood cell count | Basophil (#),Red blood cell count | Neutrophils (%),Red blood cell count | Total protein,Red blood cell count | Monocytes (%),Red blood cell count | Indirect bilirubin,Red blood cell count | chlorine,Red blood cell count | calcium,Red blood cell count | Potassium,Red blood cell count | sodium,Red blood cell count | Hypersensitive C-reactive protein,Red blood cell count | Corrected calcium,Red blood cell count | International standardized ratio,Red blood cell count | Prothrombin time,Red blood cell count | Prothrombin activity,Red blood cell count | glucose,Red blood cell count | RBC distribution width SD,Red blood cell count | RBC distribution width CV,Red blood cell count | Average PLT volume,Red blood cell count | Platelet compression,Red blood cell count | Platelet ratio,Red blood cell count | PLT distribution width,Red blood cell count | D-D dimer quantification,Red blood cell count | Procalcitonin,Red blood cell count | Thrombin time,Red blood cell count | Activated partial thromboplastin time,Red blood cell count | Fibrinogen,Red blood cell count | Erythrocyte sedimentation rate,Red blood cell count | High-sensitivity cardiac troponin I,Red blood cell count | Quantification of hepatitis C antibody,Red blood cell count | Treponema pallidum antibody quantification,Red blood cell count | Quantification of hepatitis B surface antigen,Red blood cell count | HIV antibody quantification,Red blood cell count | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Red blood cell count | PH,Red blood cell count | Interleukin 6,Red blood cell count | Tumor necrosis factor alpha,Red blood cell count | Interleukin 8,Red blood cell count | Interleukin 1-Beta,Red blood cell count | Interleukin 2 receptor,Red blood cell count | Interleukin 10,Red blood cell count | Ferritin,Red blood cell count | Antithrombin,Red blood cell count | Fibrin (pro) degradation products,White blood cell count | Hematocrit,White blood cell count | globulin,White blood cell count | Mean hemoglobin concentration,White blood cell count | Monocytes (#),White blood cell count | Lactate dehydrogenase,White blood cell count | Urea,White blood cell count | Lymphocyte (#),White blood cell count | Gamma-glutamyl transpeptidase,White blood cell count | Eosinophil (#),White blood cell count | Creatinine,White blood cell count | Neutrophils (#),White blood cell count | Direct bilirubin,White blood cell count | Bicarbonate,White blood cell count | Uric acid,White blood cell count | Aspartate aminotransferase,White blood cell count | Average RBC volume,White blood cell count | Total cholesterol,White blood cell count | Lymphocytes (%),White blood cell count | Platelet count,White blood cell count | Eosinophils (%),White blood cell count | albumin,White blood cell count | Basophil (%),White blood cell count | eGFR (based on CKD-EPI equation),White blood cell count | Total bilirubin,White blood cell count | Alkaline phosphatase,White blood cell count | Alanine aminotransferase,White blood cell count | Hemoglobin,White blood cell count | Mean hemoglobin content,White blood cell count | Basophil (#),White blood cell count | Neutrophils (%),White blood cell count | Total protein,White blood cell count | Monocytes (%),White blood cell count | Indirect bilirubin,White blood cell count | chlorine,White blood cell count | calcium,White blood cell count | Potassium,White blood cell count | sodium,White blood cell count | Hypersensitive C-reactive protein,White blood cell count | Corrected calcium,White blood cell count | International standardized ratio,White blood cell count | Prothrombin time,White blood cell count | Prothrombin activity,White blood cell count | glucose,White blood cell count | RBC distribution width SD,White blood cell count | RBC distribution width CV,White blood cell count | Average PLT volume,White blood cell count | Platelet compression,White blood cell count | Platelet ratio,White blood cell count | PLT distribution width,White blood cell count | D-D dimer quantification,White blood cell count | Procalcitonin,White blood cell count | Thrombin time,White blood cell count | Activated partial thromboplastin time,White blood cell count | Fibrinogen,White blood cell count | Erythrocyte sedimentation rate,White blood cell count | High-sensitivity cardiac troponin I,White blood cell count | Quantification of hepatitis C antibody,White blood cell count | Treponema pallidum antibody quantification,White blood cell count | Quantification of hepatitis B surface antigen,White blood cell count | HIV antibody quantification,White blood cell count | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),White blood cell count | PH,White blood cell count | Interleukin 6,White blood cell count | Tumor necrosis factor alpha,White blood cell count | Interleukin 8,White blood cell count | Interleukin 1-Beta,White blood cell count | Interleukin 2 receptor,White blood cell count | Interleukin 10,White blood cell count | Ferritin,White blood cell count | Antithrombin,White blood cell count | Fibrin (pro) degradation products,Hematocrit | globulin,Hematocrit | Mean hemoglobin concentration,Hematocrit | Monocytes (#),Hematocrit | Lactate dehydrogenase,Hematocrit | Urea,Hematocrit | Lymphocyte (#),Hematocrit | Gamma-glutamyl transpeptidase,Hematocrit | Eosinophil (#),Hematocrit | Creatinine,Hematocrit | Neutrophils (#),Hematocrit | Direct bilirubin,Hematocrit | Bicarbonate,Hematocrit | Uric acid,Hematocrit | Aspartate aminotransferase,Hematocrit | Average RBC volume,Hematocrit | Total cholesterol,Hematocrit | Lymphocytes (%),Hematocrit | Platelet count,Hematocrit | Eosinophils (%),Hematocrit | albumin,Hematocrit | Basophil (%),Hematocrit | eGFR (based on CKD-EPI equation),Hematocrit | Total bilirubin,Hematocrit | Alkaline phosphatase,Hematocrit | Alanine aminotransferase,Hematocrit | Hemoglobin,Hematocrit | Mean hemoglobin content,Hematocrit | Basophil (#),Hematocrit | Neutrophils (%),Hematocrit | Total protein,Hematocrit | Monocytes (%),Hematocrit | Indirect bilirubin,Hematocrit | chlorine,Hematocrit | calcium,Hematocrit | Potassium,Hematocrit | sodium,Hematocrit | Hypersensitive C-reactive protein,Hematocrit | Corrected calcium,Hematocrit | International standardized ratio,Hematocrit | Prothrombin time,Hematocrit | Prothrombin activity,Hematocrit | glucose,Hematocrit | RBC distribution width SD,Hematocrit | RBC distribution width CV,Hematocrit | Average PLT volume,Hematocrit | Platelet compression,Hematocrit | Platelet ratio,Hematocrit | PLT distribution width,Hematocrit | D-D dimer quantification,Hematocrit | Procalcitonin,Hematocrit | Thrombin time,Hematocrit | Activated partial thromboplastin time,Hematocrit | Fibrinogen,Hematocrit | Erythrocyte sedimentation rate,Hematocrit | High-sensitivity cardiac troponin I,Hematocrit | Quantification of hepatitis C antibody,Hematocrit | Treponema pallidum antibody quantification,Hematocrit | Quantification of hepatitis B surface antigen,Hematocrit | HIV antibody quantification,Hematocrit | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Hematocrit | PH,Hematocrit | Interleukin 6,Hematocrit | Tumor necrosis factor alpha,Hematocrit | Interleukin 8,Hematocrit | Interleukin 1-Beta,Hematocrit | Interleukin 2 receptor,Hematocrit | Interleukin 10,Hematocrit | Ferritin,Hematocrit | Antithrombin,Hematocrit | Fibrin (pro) degradation products,globulin | Mean hemoglobin concentration,globulin | Monocytes (#),globulin | Lactate dehydrogenase,globulin | Urea,globulin | Lymphocyte (#),globulin | Gamma-glutamyl transpeptidase,globulin | Eosinophil (#),globulin | Creatinine,globulin | Neutrophils (#),globulin | Direct bilirubin,globulin | Bicarbonate,globulin | Uric acid,globulin | Aspartate aminotransferase,globulin | Average RBC volume,globulin | Total cholesterol,globulin | Lymphocytes (%),globulin | Platelet count,globulin | Eosinophils (%),globulin | albumin,globulin | Basophil (%),globulin | eGFR (based on CKD-EPI equation),globulin | Total bilirubin,globulin | Alkaline phosphatase,globulin | Alanine aminotransferase,globulin | Hemoglobin,globulin | Mean hemoglobin content,globulin | Basophil (#),globulin | Neutrophils (%),globulin | Total protein,globulin | Monocytes (%),globulin | Indirect bilirubin,globulin | chlorine,globulin | calcium,globulin | Potassium,globulin | sodium,globulin | Hypersensitive C-reactive protein,globulin | Corrected calcium,globulin | International standardized ratio,globulin | Prothrombin time,globulin | Prothrombin activity,globulin | glucose,globulin | RBC distribution width SD,globulin | RBC distribution width CV,globulin | Average PLT volume,globulin | Platelet compression,globulin | Platelet ratio,globulin | PLT distribution width,globulin | D-D dimer quantification,globulin | Procalcitonin,globulin | Thrombin time,globulin | Activated partial thromboplastin time,globulin | Fibrinogen,globulin | Erythrocyte sedimentation rate,globulin | High-sensitivity cardiac troponin I,globulin | Quantification of hepatitis C antibody,globulin | Treponema pallidum antibody quantification,globulin | Quantification of hepatitis B surface antigen,globulin | HIV antibody quantification,globulin | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),globulin | PH,globulin | Interleukin 6,globulin | Tumor necrosis factor alpha,globulin | Interleukin 8,globulin | Interleukin 1-Beta,globulin | Interleukin 2 receptor,globulin | Interleukin 10,globulin | Ferritin,globulin | Antithrombin,globulin | Fibrin (pro) degradation products,Mean hemoglobin concentration | Monocytes (#),Mean hemoglobin concentration | Lactate dehydrogenase,Mean hemoglobin concentration | Urea,Mean hemoglobin concentration | Lymphocyte (#),Mean hemoglobin concentration | Gamma-glutamyl transpeptidase,Mean hemoglobin concentration | Eosinophil (#),Mean hemoglobin concentration | Creatinine,Mean hemoglobin concentration | Neutrophils (#),Mean hemoglobin concentration | Direct bilirubin,Mean hemoglobin concentration | Bicarbonate,Mean hemoglobin concentration | Uric acid,Mean hemoglobin concentration | Aspartate aminotransferase,Mean hemoglobin concentration | Average RBC volume,Mean hemoglobin concentration | Total cholesterol,Mean hemoglobin concentration | Lymphocytes (%),Mean hemoglobin concentration | Platelet count,Mean hemoglobin concentration | Eosinophils (%),Mean hemoglobin concentration | albumin,Mean hemoglobin concentration | Basophil (%),Mean hemoglobin concentration | eGFR (based on CKD-EPI equation),Mean hemoglobin concentration | Total bilirubin,Mean hemoglobin concentration | Alkaline phosphatase,Mean hemoglobin concentration | Alanine aminotransferase,Mean hemoglobin concentration | Hemoglobin,Mean hemoglobin concentration | Mean hemoglobin content,Mean hemoglobin concentration | Basophil (#),Mean hemoglobin concentration | Neutrophils (%),Mean hemoglobin concentration | Total protein,Mean hemoglobin concentration | Monocytes (%),Mean hemoglobin concentration | Indirect bilirubin,Mean hemoglobin concentration | chlorine,Mean hemoglobin concentration | calcium,Mean hemoglobin concentration | Potassium,Mean hemoglobin concentration | sodium,Mean hemoglobin concentration | Hypersensitive C-reactive protein,Mean hemoglobin concentration | Corrected calcium,Mean hemoglobin concentration | International standardized ratio,Mean hemoglobin concentration | Prothrombin time,Mean hemoglobin concentration | Prothrombin activity,Mean hemoglobin concentration | glucose,Mean hemoglobin concentration | RBC distribution width SD,Mean hemoglobin concentration | RBC distribution width CV,Mean hemoglobin concentration | Average PLT volume,Mean hemoglobin concentration | Platelet compression,Mean hemoglobin concentration | Platelet ratio,Mean hemoglobin concentration | PLT distribution width,Mean hemoglobin concentration | D-D dimer quantification,Mean hemoglobin concentration | Procalcitonin,Mean hemoglobin concentration | Thrombin time,Mean hemoglobin concentration | Activated partial thromboplastin time,Mean hemoglobin concentration | Fibrinogen,Mean hemoglobin concentration | Erythrocyte sedimentation rate,Mean hemoglobin concentration | High-sensitivity cardiac troponin I,Mean hemoglobin concentration | Quantification of hepatitis C antibody,Mean hemoglobin concentration | Treponema pallidum antibody quantification,Mean hemoglobin concentration | Quantification of hepatitis B surface antigen,Mean hemoglobin concentration | HIV antibody quantification,Mean hemoglobin concentration | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Mean hemoglobin concentration | PH,Mean hemoglobin concentration | Interleukin 6,Mean hemoglobin concentration | Tumor necrosis factor alpha,Mean hemoglobin concentration | Interleukin 8,Mean hemoglobin concentration | Interleukin 1-Beta,Mean hemoglobin concentration | Interleukin 2 receptor,Mean hemoglobin concentration | Interleukin 10,Mean hemoglobin concentration | Ferritin,Mean hemoglobin concentration | Antithrombin,Mean hemoglobin concentration | Fibrin (pro) degradation products,Monocytes (#) | Lactate dehydrogenase,Monocytes (#) | Urea,Monocytes (#) | Lymphocyte (#),Monocytes (#) | Gamma-glutamyl transpeptidase,Monocytes (#) | Eosinophil (#),Monocytes (#) | Creatinine,Monocytes (#) | Neutrophils (#),Monocytes (#) | Direct bilirubin,Monocytes (#) | Bicarbonate,Monocytes (#) | Uric acid,Monocytes (#) | Aspartate aminotransferase,Monocytes (#) | Average RBC volume,Monocytes (#) | Total cholesterol,Monocytes (#) | Lymphocytes (%),Monocytes (#) | Platelet count,Monocytes (#) | Eosinophils (%),Monocytes (#) | albumin,Monocytes (#) | Basophil (%),Monocytes (#) | eGFR (based on CKD-EPI equation),Monocytes (#) | Total bilirubin,Monocytes (#) | Alkaline phosphatase,Monocytes (#) | Alanine aminotransferase,Monocytes (#) | Hemoglobin,Monocytes (#) | Mean hemoglobin content,Monocytes (#) | Basophil (#),Monocytes (#) | Neutrophils (%),Monocytes (#) | Total protein,Monocytes (#) | Monocytes (%),Monocytes (#) | Indirect bilirubin,Monocytes (#) | chlorine,Monocytes (#) | calcium,Monocytes (#) | Potassium,Monocytes (#) | sodium,Monocytes (#) | Hypersensitive C-reactive protein,Monocytes (#) | Corrected calcium,Monocytes (#) | International standardized ratio,Monocytes (#) | Prothrombin time,Monocytes (#) | Prothrombin activity,Monocytes (#) | glucose,Monocytes (#) | RBC distribution width SD,Monocytes (#) | RBC distribution width CV,Monocytes (#) | Average PLT volume,Monocytes (#) | Platelet compression,Monocytes (#) | Platelet ratio,Monocytes (#) | PLT distribution width,Monocytes (#) | D-D dimer quantification,Monocytes (#) | Procalcitonin,Monocytes (#) | Thrombin time,Monocytes (#) | Activated partial thromboplastin time,Monocytes (#) | Fibrinogen,Monocytes (#) | Erythrocyte sedimentation rate,Monocytes (#) | High-sensitivity cardiac troponin I,Monocytes (#) | Quantification of hepatitis C antibody,Monocytes (#) | Treponema pallidum antibody quantification,Monocytes (#) | Quantification of hepatitis B surface antigen,Monocytes (#) | HIV antibody quantification,Monocytes (#) | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Monocytes (#) | PH,Monocytes (#) | Interleukin 6,Monocytes (#) | Tumor necrosis factor alpha,Monocytes (#) | Interleukin 8,Monocytes (#) | Interleukin 1-Beta,Monocytes (#) | Interleukin 2 receptor,Monocytes (#) | Interleukin 10,Monocytes (#) | Ferritin,Monocytes (#) | Antithrombin,Monocytes (#) | Fibrin (pro) degradation products,Lactate dehydrogenase | Urea,Lactate dehydrogenase | Lymphocyte (#),Lactate dehydrogenase | Gamma-glutamyl transpeptidase,Lactate dehydrogenase | Eosinophil (#),Lactate dehydrogenase | Creatinine,Lactate dehydrogenase | Neutrophils (#),Lactate dehydrogenase | Direct bilirubin,Lactate dehydrogenase | Bicarbonate,Lactate dehydrogenase | Uric acid,Lactate dehydrogenase | Aspartate aminotransferase,Lactate dehydrogenase | Average RBC volume,Lactate dehydrogenase | Total cholesterol,Lactate dehydrogenase | Lymphocytes (%),Lactate dehydrogenase | Platelet count,Lactate dehydrogenase | Eosinophils (%),Lactate dehydrogenase | albumin,Lactate dehydrogenase | Basophil (%),Lactate dehydrogenase | eGFR (based on CKD-EPI equation),Lactate dehydrogenase | Total bilirubin,Lactate dehydrogenase | Alkaline phosphatase,Lactate dehydrogenase | Alanine aminotransferase,Lactate dehydrogenase | Hemoglobin,Lactate dehydrogenase | Mean hemoglobin content,Lactate dehydrogenase | Basophil (#),Lactate dehydrogenase | Neutrophils (%),Lactate dehydrogenase | Total protein,Lactate dehydrogenase | Monocytes (%),Lactate dehydrogenase | Indirect bilirubin,Lactate dehydrogenase | chlorine,Lactate dehydrogenase | calcium,Lactate dehydrogenase | Potassium,Lactate dehydrogenase | sodium,Lactate dehydrogenase | Hypersensitive C-reactive protein,Lactate dehydrogenase | Corrected calcium,Lactate dehydrogenase | International standardized ratio,Lactate dehydrogenase | Prothrombin time,Lactate dehydrogenase | Prothrombin activity,Lactate dehydrogenase | glucose,Lactate dehydrogenase | RBC distribution width SD,Lactate dehydrogenase | RBC distribution width CV,Lactate dehydrogenase | Average PLT volume,Lactate dehydrogenase | Platelet compression,Lactate dehydrogenase | Platelet ratio,Lactate dehydrogenase | PLT distribution width,Lactate dehydrogenase | D-D dimer quantification,Lactate dehydrogenase | Procalcitonin,Lactate dehydrogenase | Thrombin time,Lactate dehydrogenase | Activated partial thromboplastin time,Lactate dehydrogenase | Fibrinogen,Lactate dehydrogenase | Erythrocyte sedimentation rate,Lactate dehydrogenase | High-sensitivity cardiac troponin I,Lactate dehydrogenase | Quantification of hepatitis C antibody,Lactate dehydrogenase | Treponema pallidum antibody quantification,Lactate dehydrogenase | Quantification of hepatitis B surface antigen,Lactate dehydrogenase | HIV antibody quantification,Lactate dehydrogenase | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Lactate dehydrogenase | PH,Lactate dehydrogenase | Interleukin 6,Lactate dehydrogenase | Tumor necrosis factor alpha,Lactate dehydrogenase | Interleukin 8,Lactate dehydrogenase | Interleukin 1-Beta,Lactate dehydrogenase | Interleukin 2 receptor,Lactate dehydrogenase | Interleukin 10,Lactate dehydrogenase | Ferritin,Lactate dehydrogenase | Antithrombin,Lactate dehydrogenase | Fibrin (pro) degradation products,Urea | Lymphocyte (#),Urea | Gamma-glutamyl transpeptidase,Urea | Eosinophil (#),Urea | Creatinine,Urea | Neutrophils (#),Urea | Direct bilirubin,Urea | Bicarbonate,Urea | Uric acid,Urea | Aspartate aminotransferase,Urea | Average RBC volume,Urea | Total cholesterol,Urea | Lymphocytes (%),Urea | Platelet count,Urea | Eosinophils (%),Urea | albumin,Urea | Basophil (%),Urea | eGFR (based on CKD-EPI equation),Urea | Total bilirubin,Urea | Alkaline phosphatase,Urea | Alanine aminotransferase,Urea | Hemoglobin,Urea | Mean hemoglobin content,Urea | Basophil (#),Urea | Neutrophils (%),Urea | Total protein,Urea | Monocytes (%),Urea | Indirect bilirubin,Urea | chlorine,Urea | calcium,Urea | Potassium,Urea | sodium,Urea | Hypersensitive C-reactive protein,Urea | Corrected calcium,Urea | International standardized ratio,Urea | Prothrombin time,Urea | Prothrombin activity,Urea | glucose,Urea | RBC distribution width SD,Urea | RBC distribution width CV,Urea | Average PLT volume,Urea | Platelet compression,Urea | Platelet ratio,Urea | PLT distribution width,Urea | D-D dimer quantification,Urea | Procalcitonin,Urea | Thrombin time,Urea | Activated partial thromboplastin time,Urea | Fibrinogen,Urea | Erythrocyte sedimentation rate,Urea | High-sensitivity cardiac troponin I,Urea | Quantification of hepatitis C antibody,Urea | Treponema pallidum antibody quantification,Urea | Quantification of hepatitis B surface antigen,Urea | HIV antibody quantification,Urea | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Urea | PH,Urea | Interleukin 6,Urea | Tumor necrosis factor alpha,Urea | Interleukin 8,Urea | Interleukin 1-Beta,Urea | Interleukin 2 receptor,Urea | Interleukin 10,Urea | Ferritin,Urea | Antithrombin,Urea | Fibrin (pro) degradation products,Lymphocyte (#) | Gamma-glutamyl transpeptidase,Lymphocyte (#) | Eosinophil (#),Lymphocyte (#) | Creatinine,Lymphocyte (#) | Neutrophils (#),Lymphocyte (#) | Direct bilirubin,Lymphocyte (#) | Bicarbonate,Lymphocyte (#) | Uric acid,Lymphocyte (#) | Aspartate aminotransferase,Lymphocyte (#) | Average RBC volume,Lymphocyte (#) | Total cholesterol,Lymphocyte (#) | Lymphocytes (%),Lymphocyte (#) | Platelet count,Lymphocyte (#) | Eosinophils (%),Lymphocyte (#) | albumin,Lymphocyte (#) | Basophil (%),Lymphocyte (#) | eGFR (based on CKD-EPI equation),Lymphocyte (#) | Total bilirubin,Lymphocyte (#) | Alkaline phosphatase,Lymphocyte (#) | Alanine aminotransferase,Lymphocyte (#) | Hemoglobin,Lymphocyte (#) | Mean hemoglobin content,Lymphocyte (#) | Basophil (#),Lymphocyte (#) | Neutrophils (%),Lymphocyte (#) | Total protein,Lymphocyte (#) | Monocytes (%),Lymphocyte (#) | Indirect bilirubin,Lymphocyte (#) | chlorine,Lymphocyte (#) | calcium,Lymphocyte (#) | Potassium,Lymphocyte (#) | sodium,Lymphocyte (#) | Hypersensitive C-reactive protein,Lymphocyte (#) | Corrected calcium,Lymphocyte (#) | International standardized ratio,Lymphocyte (#) | Prothrombin time,Lymphocyte (#) | Prothrombin activity,Lymphocyte (#) | glucose,Lymphocyte (#) | RBC distribution width SD,Lymphocyte (#) | RBC distribution width CV,Lymphocyte (#) | Average PLT volume,Lymphocyte (#) | Platelet compression,Lymphocyte (#) | Platelet ratio,Lymphocyte (#) | PLT distribution width,Lymphocyte (#) | D-D dimer quantification,Lymphocyte (#) | Procalcitonin,Lymphocyte (#) | Thrombin time,Lymphocyte (#) | Activated partial thromboplastin time,Lymphocyte (#) | Fibrinogen,Lymphocyte (#) | Erythrocyte sedimentation rate,Lymphocyte (#) | High-sensitivity cardiac troponin I,Lymphocyte (#) | Quantification of hepatitis C antibody,Lymphocyte (#) | Treponema pallidum antibody quantification,Lymphocyte (#) | Quantification of hepatitis B surface antigen,Lymphocyte (#) | HIV antibody quantification,Lymphocyte (#) | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Lymphocyte (#) | PH,Lymphocyte (#) | Interleukin 6,Lymphocyte (#) | Tumor necrosis factor alpha,Lymphocyte (#) | Interleukin 8,Lymphocyte (#) | Interleukin 1-Beta,Lymphocyte (#) | Interleukin 2 receptor,Lymphocyte (#) | Interleukin 10,Lymphocyte (#) | Ferritin,Lymphocyte (#) | Antithrombin,Lymphocyte (#) | Fibrin (pro) degradation products,Gamma-glutamyl transpeptidase | Eosinophil (#),Gamma-glutamyl transpeptidase | Creatinine,Gamma-glutamyl transpeptidase | Neutrophils (#),Gamma-glutamyl transpeptidase | Direct bilirubin,Gamma-glutamyl transpeptidase | Bicarbonate,Gamma-glutamyl transpeptidase | Uric acid,Gamma-glutamyl transpeptidase | Aspartate aminotransferase,Gamma-glutamyl transpeptidase | Average RBC volume,Gamma-glutamyl transpeptidase | Total cholesterol,Gamma-glutamyl transpeptidase | Lymphocytes (%),Gamma-glutamyl transpeptidase | Platelet count,Gamma-glutamyl transpeptidase | Eosinophils (%),Gamma-glutamyl transpeptidase | albumin,Gamma-glutamyl transpeptidase | Basophil (%),Gamma-glutamyl transpeptidase | eGFR (based on CKD-EPI equation),Gamma-glutamyl transpeptidase | Total bilirubin,Gamma-glutamyl transpeptidase | Alkaline phosphatase,Gamma-glutamyl transpeptidase | Alanine aminotransferase,Gamma-glutamyl transpeptidase | Hemoglobin,Gamma-glutamyl transpeptidase | Mean hemoglobin content,Gamma-glutamyl transpeptidase | Basophil (#),Gamma-glutamyl transpeptidase | Neutrophils (%),Gamma-glutamyl transpeptidase | Total protein,Gamma-glutamyl transpeptidase | Monocytes (%),Gamma-glutamyl transpeptidase | Indirect bilirubin,Gamma-glutamyl transpeptidase | chlorine,Gamma-glutamyl transpeptidase | calcium,Gamma-glutamyl transpeptidase | Potassium,Gamma-glutamyl transpeptidase | sodium,Gamma-glutamyl transpeptidase | Hypersensitive C-reactive protein,Gamma-glutamyl transpeptidase | Corrected calcium,Gamma-glutamyl transpeptidase | International standardized ratio,Gamma-glutamyl transpeptidase | Prothrombin time,Gamma-glutamyl transpeptidase | Prothrombin activity,Gamma-glutamyl transpeptidase | glucose,Gamma-glutamyl transpeptidase | RBC distribution width SD,Gamma-glutamyl transpeptidase | RBC distribution width CV,Gamma-glutamyl transpeptidase | Average PLT volume,Gamma-glutamyl transpeptidase | Platelet compression,Gamma-glutamyl transpeptidase | Platelet ratio,Gamma-glutamyl transpeptidase | PLT distribution width,Gamma-glutamyl transpeptidase | D-D dimer quantification,Gamma-glutamyl transpeptidase | Procalcitonin,Gamma-glutamyl transpeptidase | Thrombin time,Gamma-glutamyl transpeptidase | Activated partial thromboplastin time,Gamma-glutamyl transpeptidase | Fibrinogen,Gamma-glutamyl transpeptidase | Erythrocyte sedimentation rate,Gamma-glutamyl transpeptidase | High-sensitivity cardiac troponin I,Gamma-glutamyl transpeptidase | Quantification of hepatitis C antibody,Gamma-glutamyl transpeptidase | Treponema pallidum antibody quantification,Gamma-glutamyl transpeptidase | Quantification of hepatitis B surface antigen,Gamma-glutamyl transpeptidase | HIV antibody quantification,Gamma-glutamyl transpeptidase | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Gamma-glutamyl transpeptidase | PH,Gamma-glutamyl transpeptidase | Interleukin 6,Gamma-glutamyl transpeptidase | Tumor necrosis factor alpha,Gamma-glutamyl transpeptidase | Interleukin 8,Gamma-glutamyl transpeptidase | Interleukin 1-Beta,Gamma-glutamyl transpeptidase | Interleukin 2 receptor,Gamma-glutamyl transpeptidase | Interleukin 10,Gamma-glutamyl transpeptidase | Ferritin,Gamma-glutamyl transpeptidase | Antithrombin,Gamma-glutamyl transpeptidase | Fibrin (pro) degradation products,Eosinophil (#) | Creatinine,Eosinophil (#) | Neutrophils (#),Eosinophil (#) | Direct bilirubin,Eosinophil (#) | Bicarbonate,Eosinophil (#) | Uric acid,Eosinophil (#) | Aspartate aminotransferase,Eosinophil (#) | Average RBC volume,Eosinophil (#) | Total cholesterol,Eosinophil (#) | Lymphocytes (%),Eosinophil (#) | Platelet count,Eosinophil (#) | Eosinophils (%),Eosinophil (#) | albumin,Eosinophil (#) | Basophil (%),Eosinophil (#) | eGFR (based on CKD-EPI equation),Eosinophil (#) | Total bilirubin,Eosinophil (#) | Alkaline phosphatase,Eosinophil (#) | Alanine aminotransferase,Eosinophil (#) | Hemoglobin,Eosinophil (#) | Mean hemoglobin content,Eosinophil (#) | Basophil (#),Eosinophil (#) | Neutrophils (%),Eosinophil (#) | Total protein,Eosinophil (#) | Monocytes (%),Eosinophil (#) | Indirect bilirubin,Eosinophil (#) | chlorine,Eosinophil (#) | calcium,Eosinophil (#) | Potassium,Eosinophil (#) | sodium,Eosinophil (#) | Hypersensitive C-reactive protein,Eosinophil (#) | Corrected calcium,Eosinophil (#) | International standardized ratio,Eosinophil (#) | Prothrombin time,Eosinophil (#) | Prothrombin activity,Eosinophil (#) | glucose,Eosinophil (#) | RBC distribution width SD,Eosinophil (#) | RBC distribution width CV,Eosinophil (#) | Average PLT volume,Eosinophil (#) | Platelet compression,Eosinophil (#) | Platelet ratio,Eosinophil (#) | PLT distribution width,Eosinophil (#) | D-D dimer quantification,Eosinophil (#) | Procalcitonin,Eosinophil (#) | Thrombin time,Eosinophil (#) | Activated partial thromboplastin time,Eosinophil (#) | Fibrinogen,Eosinophil (#) | Erythrocyte sedimentation rate,Eosinophil (#) | High-sensitivity cardiac troponin I,Eosinophil (#) | Quantification of hepatitis C antibody,Eosinophil (#) | Treponema pallidum antibody quantification,Eosinophil (#) | Quantification of hepatitis B surface antigen,Eosinophil (#) | HIV antibody quantification,Eosinophil (#) | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Eosinophil (#) | PH,Eosinophil (#) | Interleukin 6,Eosinophil (#) | Tumor necrosis factor alpha,Eosinophil (#) | Interleukin 8,Eosinophil (#) | Interleukin 1-Beta,Eosinophil (#) | Interleukin 2 receptor,Eosinophil (#) | Interleukin 10,Eosinophil (#) | Ferritin,Eosinophil (#) | Antithrombin,Eosinophil (#) | Fibrin (pro) degradation products,Creatinine | Neutrophils (#),Creatinine | Direct bilirubin,Creatinine | Bicarbonate,Creatinine | Uric acid,Creatinine | Aspartate aminotransferase,Creatinine | Average RBC volume,Creatinine | Total cholesterol,Creatinine | Lymphocytes (%),Creatinine | Platelet count,Creatinine | Eosinophils (%),Creatinine | albumin,Creatinine | Basophil (%),Creatinine | eGFR (based on CKD-EPI equation),Creatinine | Total bilirubin,Creatinine | Alkaline phosphatase,Creatinine | Alanine aminotransferase,Creatinine | Hemoglobin,Creatinine | Mean hemoglobin content,Creatinine | Basophil (#),Creatinine | Neutrophils (%),Creatinine | Total protein,Creatinine | Monocytes (%),Creatinine | Indirect bilirubin,Creatinine | chlorine,Creatinine | calcium,Creatinine | Potassium,Creatinine | sodium,Creatinine | Hypersensitive C-reactive protein,Creatinine | Corrected calcium,Creatinine | International standardized ratio,Creatinine | Prothrombin time,Creatinine | Prothrombin activity,Creatinine | glucose,Creatinine | RBC distribution width SD,Creatinine | RBC distribution width CV,Creatinine | Average PLT volume,Creatinine | Platelet compression,Creatinine | Platelet ratio,Creatinine | PLT distribution width,Creatinine | D-D dimer quantification,Creatinine | Procalcitonin,Creatinine | Thrombin time,Creatinine | Activated partial thromboplastin time,Creatinine | Fibrinogen,Creatinine | Erythrocyte sedimentation rate,Creatinine | High-sensitivity cardiac troponin I,Creatinine | Quantification of hepatitis C antibody,Creatinine | Treponema pallidum antibody quantification,Creatinine | Quantification of hepatitis B surface antigen,Creatinine | HIV antibody quantification,Creatinine | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Creatinine | PH,Creatinine | Interleukin 6,Creatinine | Tumor necrosis factor alpha,Creatinine | Interleukin 8,Creatinine | Interleukin 1-Beta,Creatinine | Interleukin 2 receptor,Creatinine | Interleukin 10,Creatinine | Ferritin,Creatinine | Antithrombin,Creatinine | Fibrin (pro) degradation products,Neutrophils (#) | Direct bilirubin,Neutrophils (#) | Bicarbonate,Neutrophils (#) | Uric acid,Neutrophils (#) | Aspartate aminotransferase,Neutrophils (#) | Average RBC volume,Neutrophils (#) | Total cholesterol,Neutrophils (#) | Lymphocytes (%),Neutrophils (#) | Platelet count,Neutrophils (#) | Eosinophils (%),Neutrophils (#) | albumin,Neutrophils (#) | Basophil (%),Neutrophils (#) | eGFR (based on CKD-EPI equation),Neutrophils (#) | Total bilirubin,Neutrophils (#) | Alkaline phosphatase,Neutrophils (#) | Alanine aminotransferase,Neutrophils (#) | Hemoglobin,Neutrophils (#) | Mean hemoglobin content,Neutrophils (#) | Basophil (#),Neutrophils (#) | Neutrophils (%),Neutrophils (#) | Total protein,Neutrophils (#) | Monocytes (%),Neutrophils (#) | Indirect bilirubin,Neutrophils (#) | chlorine,Neutrophils (#) | calcium,Neutrophils (#) | Potassium,Neutrophils (#) | sodium,Neutrophils (#) | Hypersensitive C-reactive protein,Neutrophils (#) | Corrected calcium,Neutrophils (#) | International standardized ratio,Neutrophils (#) | Prothrombin time,Neutrophils (#) | Prothrombin activity,Neutrophils (#) | glucose,Neutrophils (#) | RBC distribution width SD,Neutrophils (#) | RBC distribution width CV,Neutrophils (#) | Average PLT volume,Neutrophils (#) | Platelet compression,Neutrophils (#) | Platelet ratio,Neutrophils (#) | PLT distribution width,Neutrophils (#) | D-D dimer quantification,Neutrophils (#) | Procalcitonin,Neutrophils (#) | Thrombin time,Neutrophils (#) | Activated partial thromboplastin time,Neutrophils (#) | Fibrinogen,Neutrophils (#) | Erythrocyte sedimentation rate,Neutrophils (#) | High-sensitivity cardiac troponin I,Neutrophils (#) | Quantification of hepatitis C antibody,Neutrophils (#) | Treponema pallidum antibody quantification,Neutrophils (#) | Quantification of hepatitis B surface antigen,Neutrophils (#) | HIV antibody quantification,Neutrophils (#) | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Neutrophils (#) | PH,Neutrophils (#) | Interleukin 6,Neutrophils (#) | Tumor necrosis factor alpha,Neutrophils (#) | Interleukin 8,Neutrophils (#) | Interleukin 1-Beta,Neutrophils (#) | Interleukin 2 receptor,Neutrophils (#) | Interleukin 10,Neutrophils (#) | Ferritin,Neutrophils (#) | Antithrombin,Neutrophils (#) | Fibrin (pro) degradation products,Direct bilirubin | Bicarbonate,Direct bilirubin | Uric acid,Direct bilirubin | Aspartate aminotransferase,Direct bilirubin | Average RBC volume,Direct bilirubin | Total cholesterol,Direct bilirubin | Lymphocytes (%),Direct bilirubin | Platelet count,Direct bilirubin | Eosinophils (%),Direct bilirubin | albumin,Direct bilirubin | Basophil (%),Direct bilirubin | eGFR (based on CKD-EPI equation),Direct bilirubin | Total bilirubin,Direct bilirubin | Alkaline phosphatase,Direct bilirubin | Alanine aminotransferase,Direct bilirubin | Hemoglobin,Direct bilirubin | Mean hemoglobin content,Direct bilirubin | Basophil (#),Direct bilirubin | Neutrophils (%),Direct bilirubin | Total protein,Direct bilirubin | Monocytes (%),Direct bilirubin | Indirect bilirubin,Direct bilirubin | chlorine,Direct bilirubin | calcium,Direct bilirubin | Potassium,Direct bilirubin | sodium,Direct bilirubin | Hypersensitive C-reactive protein,Direct bilirubin | Corrected calcium,Direct bilirubin | International standardized ratio,Direct bilirubin | Prothrombin time,Direct bilirubin | Prothrombin activity,Direct bilirubin | glucose,Direct bilirubin | RBC distribution width SD,Direct bilirubin | RBC distribution width CV,Direct bilirubin | Average PLT volume,Direct bilirubin | Platelet compression,Direct bilirubin | Platelet ratio,Direct bilirubin | PLT distribution width,Direct bilirubin | D-D dimer quantification,Direct bilirubin | Procalcitonin,Direct bilirubin | Thrombin time,Direct bilirubin | Activated partial thromboplastin time,Direct bilirubin | Fibrinogen,Direct bilirubin | Erythrocyte sedimentation rate,Direct bilirubin | High-sensitivity cardiac troponin I,Direct bilirubin | Quantification of hepatitis C antibody,Direct bilirubin | Treponema pallidum antibody quantification,Direct bilirubin | Quantification of hepatitis B surface antigen,Direct bilirubin | HIV antibody quantification,Direct bilirubin | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Direct bilirubin | PH,Direct bilirubin | Interleukin 6,Direct bilirubin | Tumor necrosis factor alpha,Direct bilirubin | Interleukin 8,Direct bilirubin | Interleukin 1-Beta,Direct bilirubin | Interleukin 2 receptor,Direct bilirubin | Interleukin 10,Direct bilirubin | Ferritin,Direct bilirubin | Antithrombin,Direct bilirubin | Fibrin (pro) degradation products,Bicarbonate | Uric acid,Bicarbonate | Aspartate aminotransferase,Bicarbonate | Average RBC volume,Bicarbonate | Total cholesterol,Bicarbonate | Lymphocytes (%),Bicarbonate | Platelet count,Bicarbonate | Eosinophils (%),Bicarbonate | albumin,Bicarbonate | Basophil (%),Bicarbonate | eGFR (based on CKD-EPI equation),Bicarbonate | Total bilirubin,Bicarbonate | Alkaline phosphatase,Bicarbonate | Alanine aminotransferase,Bicarbonate | Hemoglobin,Bicarbonate | Mean hemoglobin content,Bicarbonate | Basophil (#),Bicarbonate | Neutrophils (%),Bicarbonate | Total protein,Bicarbonate | Monocytes (%),Bicarbonate | Indirect bilirubin,Bicarbonate | chlorine,Bicarbonate | calcium,Bicarbonate | Potassium,Bicarbonate | sodium,Bicarbonate | Hypersensitive C-reactive protein,Bicarbonate | Corrected calcium,Bicarbonate | International standardized ratio,Bicarbonate | Prothrombin time,Bicarbonate | Prothrombin activity,Bicarbonate | glucose,Bicarbonate | RBC distribution width SD,Bicarbonate | RBC distribution width CV,Bicarbonate | Average PLT volume,Bicarbonate | Platelet compression,Bicarbonate | Platelet ratio,Bicarbonate | PLT distribution width,Bicarbonate | D-D dimer quantification,Bicarbonate | Procalcitonin,Bicarbonate | Thrombin time,Bicarbonate | Activated partial thromboplastin time,Bicarbonate | Fibrinogen,Bicarbonate | Erythrocyte sedimentation rate,Bicarbonate | High-sensitivity cardiac troponin I,Bicarbonate | Quantification of hepatitis C antibody,Bicarbonate | Treponema pallidum antibody quantification,Bicarbonate | Quantification of hepatitis B surface antigen,Bicarbonate | HIV antibody quantification,Bicarbonate | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Bicarbonate | PH,Bicarbonate | Interleukin 6,Bicarbonate | Tumor necrosis factor alpha,Bicarbonate | Interleukin 8,Bicarbonate | Interleukin 1-Beta,Bicarbonate | Interleukin 2 receptor,Bicarbonate | Interleukin 10,Bicarbonate | Ferritin,Bicarbonate | Antithrombin,Bicarbonate | Fibrin (pro) degradation products,Uric acid | Aspartate aminotransferase,Uric acid | Average RBC volume,Uric acid | Total cholesterol,Uric acid | Lymphocytes (%),Uric acid | Platelet count,Uric acid | Eosinophils (%),Uric acid | albumin,Uric acid | Basophil (%),Uric acid | eGFR (based on CKD-EPI equation),Uric acid | Total bilirubin,Uric acid | Alkaline phosphatase,Uric acid | Alanine aminotransferase,Uric acid | Hemoglobin,Uric acid | Mean hemoglobin content,Uric acid | Basophil (#),Uric acid | Neutrophils (%),Uric acid | Total protein,Uric acid | Monocytes (%),Uric acid | Indirect bilirubin,Uric acid | chlorine,Uric acid | calcium,Uric acid | Potassium,Uric acid | sodium,Uric acid | Hypersensitive C-reactive protein,Uric acid | Corrected calcium,Uric acid | International standardized ratio,Uric acid | Prothrombin time,Uric acid | Prothrombin activity,Uric acid | glucose,Uric acid | RBC distribution width SD,Uric acid | RBC distribution width CV,Uric acid | Average PLT volume,Uric acid | Platelet compression,Uric acid | Platelet ratio,Uric acid | PLT distribution width,Uric acid | D-D dimer quantification,Uric acid | Procalcitonin,Uric acid | Thrombin time,Uric acid | Activated partial thromboplastin time,Uric acid | Fibrinogen,Uric acid | Erythrocyte sedimentation rate,Uric acid | High-sensitivity cardiac troponin I,Uric acid | Quantification of hepatitis C antibody,Uric acid | Treponema pallidum antibody quantification,Uric acid | Quantification of hepatitis B surface antigen,Uric acid | HIV antibody quantification,Uric acid | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Uric acid | PH,Uric acid | Interleukin 6,Uric acid | Tumor necrosis factor alpha,Uric acid | Interleukin 8,Uric acid | Interleukin 1-Beta,Uric acid | Interleukin 2 receptor,Uric acid | Interleukin 10,Uric acid | Ferritin,Uric acid | Antithrombin,Uric acid | Fibrin (pro) degradation products,Aspartate aminotransferase | Average RBC volume,Aspartate aminotransferase | Total cholesterol,Aspartate aminotransferase | Lymphocytes (%),Aspartate aminotransferase | Platelet count,Aspartate aminotransferase | Eosinophils (%),Aspartate aminotransferase | albumin,Aspartate aminotransferase | Basophil (%),Aspartate aminotransferase | eGFR (based on CKD-EPI equation),Aspartate aminotransferase | Total bilirubin,Aspartate aminotransferase | Alkaline phosphatase,Aspartate aminotransferase | Alanine aminotransferase,Aspartate aminotransferase | Hemoglobin,Aspartate aminotransferase | Mean hemoglobin content,Aspartate aminotransferase | Basophil (#),Aspartate aminotransferase | Neutrophils (%),Aspartate aminotransferase | Total protein,Aspartate aminotransferase | Monocytes (%),Aspartate aminotransferase | Indirect bilirubin,Aspartate aminotransferase | chlorine,Aspartate aminotransferase | calcium,Aspartate aminotransferase | Potassium,Aspartate aminotransferase | sodium,Aspartate aminotransferase | Hypersensitive C-reactive protein,Aspartate aminotransferase | Corrected calcium,Aspartate aminotransferase | International standardized ratio,Aspartate aminotransferase | Prothrombin time,Aspartate aminotransferase | Prothrombin activity,Aspartate aminotransferase | glucose,Aspartate aminotransferase | RBC distribution width SD,Aspartate aminotransferase | RBC distribution width CV,Aspartate aminotransferase | Average PLT volume,Aspartate aminotransferase | Platelet compression,Aspartate aminotransferase | Platelet ratio,Aspartate aminotransferase | PLT distribution width,Aspartate aminotransferase | D-D dimer quantification,Aspartate aminotransferase | Procalcitonin,Aspartate aminotransferase | Thrombin time,Aspartate aminotransferase | Activated partial thromboplastin time,Aspartate aminotransferase | Fibrinogen,Aspartate aminotransferase | Erythrocyte sedimentation rate,Aspartate aminotransferase | High-sensitivity cardiac troponin I,Aspartate aminotransferase | Quantification of hepatitis C antibody,Aspartate aminotransferase | Treponema pallidum antibody quantification,Aspartate aminotransferase | Quantification of hepatitis B surface antigen,Aspartate aminotransferase | HIV antibody quantification,Aspartate aminotransferase | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Aspartate aminotransferase | PH,Aspartate aminotransferase | Interleukin 6,Aspartate aminotransferase | Tumor necrosis factor alpha,Aspartate aminotransferase | Interleukin 8,Aspartate aminotransferase | Interleukin 1-Beta,Aspartate aminotransferase | Interleukin 2 receptor,Aspartate aminotransferase | Interleukin 10,Aspartate aminotransferase | Ferritin,Aspartate aminotransferase | Antithrombin,Aspartate aminotransferase | Fibrin (pro) degradation products,Average RBC volume | Total cholesterol,Average RBC volume | Lymphocytes (%),Average RBC volume | Platelet count,Average RBC volume | Eosinophils (%),Average RBC volume | albumin,Average RBC volume | Basophil (%),Average RBC volume | eGFR (based on CKD-EPI equation),Average RBC volume | Total bilirubin,Average RBC volume | Alkaline phosphatase,Average RBC volume | Alanine aminotransferase,Average RBC volume | Hemoglobin,Average RBC volume | Mean hemoglobin content,Average RBC volume | Basophil (#),Average RBC volume | Neutrophils (%),Average RBC volume | Total protein,Average RBC volume | Monocytes (%),Average RBC volume | Indirect bilirubin,Average RBC volume | chlorine,Average RBC volume | calcium,Average RBC volume | Potassium,Average RBC volume | sodium,Average RBC volume | Hypersensitive C-reactive protein,Average RBC volume | Corrected calcium,Average RBC volume | International standardized ratio,Average RBC volume | Prothrombin time,Average RBC volume | Prothrombin activity,Average RBC volume | glucose,Average RBC volume | RBC distribution width SD,Average RBC volume | RBC distribution width CV,Average RBC volume | Average PLT volume,Average RBC volume | Platelet compression,Average RBC volume | Platelet ratio,Average RBC volume | PLT distribution width,Average RBC volume | D-D dimer quantification,Average RBC volume | Procalcitonin,Average RBC volume | Thrombin time,Average RBC volume | Activated partial thromboplastin time,Average RBC volume | Fibrinogen,Average RBC volume | Erythrocyte sedimentation rate,Average RBC volume | High-sensitivity cardiac troponin I,Average RBC volume | Quantification of hepatitis C antibody,Average RBC volume | Treponema pallidum antibody quantification,Average RBC volume | Quantification of hepatitis B surface antigen,Average RBC volume | HIV antibody quantification,Average RBC volume | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Average RBC volume | PH,Average RBC volume | Interleukin 6,Average RBC volume | Tumor necrosis factor alpha,Average RBC volume | Interleukin 8,Average RBC volume | Interleukin 1-Beta,Average RBC volume | Interleukin 2 receptor,Average RBC volume | Interleukin 10,Average RBC volume | Ferritin,Average RBC volume | Antithrombin,Average RBC volume | Fibrin (pro) degradation products,Total cholesterol | Lymphocytes (%),Total cholesterol | Platelet count,Total cholesterol | Eosinophils (%),Total cholesterol | albumin,Total cholesterol | Basophil (%),Total cholesterol | eGFR (based on CKD-EPI equation),Total cholesterol | Total bilirubin,Total cholesterol | Alkaline phosphatase,Total cholesterol | Alanine aminotransferase,Total cholesterol | Hemoglobin,Total cholesterol | Mean hemoglobin content,Total cholesterol | Basophil (#),Total cholesterol | Neutrophils (%),Total cholesterol | Total protein,Total cholesterol | Monocytes (%),Total cholesterol | Indirect bilirubin,Total cholesterol | chlorine,Total cholesterol | calcium,Total cholesterol | Potassium,Total cholesterol | sodium,Total cholesterol | Hypersensitive C-reactive protein,Total cholesterol | Corrected calcium,Total cholesterol | International standardized ratio,Total cholesterol | Prothrombin time,Total cholesterol | Prothrombin activity,Total cholesterol | glucose,Total cholesterol | RBC distribution width SD,Total cholesterol | RBC distribution width CV,Total cholesterol | Average PLT volume,Total cholesterol | Platelet compression,Total cholesterol | Platelet ratio,Total cholesterol | PLT distribution width,Total cholesterol | D-D dimer quantification,Total cholesterol | Procalcitonin,Total cholesterol | Thrombin time,Total cholesterol | Activated partial thromboplastin time,Total cholesterol | Fibrinogen,Total cholesterol | Erythrocyte sedimentation rate,Total cholesterol | High-sensitivity cardiac troponin I,Total cholesterol | Quantification of hepatitis C antibody,Total cholesterol | Treponema pallidum antibody quantification,Total cholesterol | Quantification of hepatitis B surface antigen,Total cholesterol | HIV antibody quantification,Total cholesterol | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Total cholesterol | PH,Total cholesterol | Interleukin 6,Total cholesterol | Tumor necrosis factor alpha,Total cholesterol | Interleukin 8,Total cholesterol | Interleukin 1-Beta,Total cholesterol | Interleukin 2 receptor,Total cholesterol | Interleukin 10,Total cholesterol | Ferritin,Total cholesterol | Antithrombin,Total cholesterol | Fibrin (pro) degradation products,Lymphocytes (%) | Platelet count,Lymphocytes (%) | Eosinophils (%),Lymphocytes (%) | albumin,Lymphocytes (%) | Basophil (%),Lymphocytes (%) | eGFR (based on CKD-EPI equation),Lymphocytes (%) | Total bilirubin,Lymphocytes (%) | Alkaline phosphatase,Lymphocytes (%) | Alanine aminotransferase,Lymphocytes (%) | Hemoglobin,Lymphocytes (%) | Mean hemoglobin content,Lymphocytes (%) | Basophil (#),Lymphocytes (%) | Neutrophils (%),Lymphocytes (%) | Total protein,Lymphocytes (%) | Monocytes (%),Lymphocytes (%) | Indirect bilirubin,Lymphocytes (%) | chlorine,Lymphocytes (%) | calcium,Lymphocytes (%) | Potassium,Lymphocytes (%) | sodium,Lymphocytes (%) | Hypersensitive C-reactive protein,Lymphocytes (%) | Corrected calcium,Lymphocytes (%) | International standardized ratio,Lymphocytes (%) | Prothrombin time,Lymphocytes (%) | Prothrombin activity,Lymphocytes (%) | glucose,Lymphocytes (%) | RBC distribution width SD,Lymphocytes (%) | RBC distribution width CV,Lymphocytes (%) | Average PLT volume,Lymphocytes (%) | Platelet compression,Lymphocytes (%) | Platelet ratio,Lymphocytes (%) | PLT distribution width,Lymphocytes (%) | D-D dimer quantification,Lymphocytes (%) | Procalcitonin,Lymphocytes (%) | Thrombin time,Lymphocytes (%) | Activated partial thromboplastin time,Lymphocytes (%) | Fibrinogen,Lymphocytes (%) | Erythrocyte sedimentation rate,Lymphocytes (%) | High-sensitivity cardiac troponin I,Lymphocytes (%) | Quantification of hepatitis C antibody,Lymphocytes (%) | Treponema pallidum antibody quantification,Lymphocytes (%) | Quantification of hepatitis B surface antigen,Lymphocytes (%) | HIV antibody quantification,Lymphocytes (%) | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Lymphocytes (%) | PH,Lymphocytes (%) | Interleukin 6,Lymphocytes (%) | Tumor necrosis factor alpha,Lymphocytes (%) | Interleukin 8,Lymphocytes (%) | Interleukin 1-Beta,Lymphocytes (%) | Interleukin 2 receptor,Lymphocytes (%) | Interleukin 10,Lymphocytes (%) | Ferritin,Lymphocytes (%) | Antithrombin,Lymphocytes (%) | Fibrin (pro) degradation products,Platelet count | Eosinophils (%),Platelet count | albumin,Platelet count | Basophil (%),Platelet count | eGFR (based on CKD-EPI equation),Platelet count | Total bilirubin,Platelet count | Alkaline phosphatase,Platelet count | Alanine aminotransferase,Platelet count | Hemoglobin,Platelet count | Mean hemoglobin content,Platelet count | Basophil (#),Platelet count | Neutrophils (%),Platelet count | Total protein,Platelet count | Monocytes (%),Platelet count | Indirect bilirubin,Platelet count | chlorine,Platelet count | calcium,Platelet count | Potassium,Platelet count | sodium,Platelet count | Hypersensitive C-reactive protein,Platelet count | Corrected calcium,Platelet count | International standardized ratio,Platelet count | Prothrombin time,Platelet count | Prothrombin activity,Platelet count | glucose,Platelet count | RBC distribution width SD,Platelet count | RBC distribution width CV,Platelet count | Average PLT volume,Platelet count | Platelet compression,Platelet count | Platelet ratio,Platelet count | PLT distribution width,Platelet count | D-D dimer quantification,Platelet count | Procalcitonin,Platelet count | Thrombin time,Platelet count | Activated partial thromboplastin time,Platelet count | Fibrinogen,Platelet count | Erythrocyte sedimentation rate,Platelet count | High-sensitivity cardiac troponin I,Platelet count | Quantification of hepatitis C antibody,Platelet count | Treponema pallidum antibody quantification,Platelet count | Quantification of hepatitis B surface antigen,Platelet count | HIV antibody quantification,Platelet count | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Platelet count | PH,Platelet count | Interleukin 6,Platelet count | Tumor necrosis factor alpha,Platelet count | Interleukin 8,Platelet count | Interleukin 1-Beta,Platelet count | Interleukin 2 receptor,Platelet count | Interleukin 10,Platelet count | Ferritin,Platelet count | Antithrombin,Platelet count | Fibrin (pro) degradation products,Eosinophils (%) | albumin,Eosinophils (%) | Basophil (%),Eosinophils (%) | eGFR (based on CKD-EPI equation),Eosinophils (%) | Total bilirubin,Eosinophils (%) | Alkaline phosphatase,Eosinophils (%) | Alanine aminotransferase,Eosinophils (%) | Hemoglobin,Eosinophils (%) | Mean hemoglobin content,Eosinophils (%) | Basophil (#),Eosinophils (%) | Neutrophils (%),Eosinophils (%) | Total protein,Eosinophils (%) | Monocytes (%),Eosinophils (%) | Indirect bilirubin,Eosinophils (%) | chlorine,Eosinophils (%) | calcium,Eosinophils (%) | Potassium,Eosinophils (%) | sodium,Eosinophils (%) | Hypersensitive C-reactive protein,Eosinophils (%) | Corrected calcium,Eosinophils (%) | International standardized ratio,Eosinophils (%) | Prothrombin time,Eosinophils (%) | Prothrombin activity,Eosinophils (%) | glucose,Eosinophils (%) | RBC distribution width SD,Eosinophils (%) | RBC distribution width CV,Eosinophils (%) | Average PLT volume,Eosinophils (%) | Platelet compression,Eosinophils (%) | Platelet ratio,Eosinophils (%) | PLT distribution width,Eosinophils (%) | D-D dimer quantification,Eosinophils (%) | Procalcitonin,Eosinophils (%) | Thrombin time,Eosinophils (%) | Activated partial thromboplastin time,Eosinophils (%) | Fibrinogen,Eosinophils (%) | Erythrocyte sedimentation rate,Eosinophils (%) | High-sensitivity cardiac troponin I,Eosinophils (%) | Quantification of hepatitis C antibody,Eosinophils (%) | Treponema pallidum antibody quantification,Eosinophils (%) | Quantification of hepatitis B surface antigen,Eosinophils (%) | HIV antibody quantification,Eosinophils (%) | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Eosinophils (%) | PH,Eosinophils (%) | Interleukin 6,Eosinophils (%) | Tumor necrosis factor alpha,Eosinophils (%) | Interleukin 8,Eosinophils (%) | Interleukin 1-Beta,Eosinophils (%) | Interleukin 2 receptor,Eosinophils (%) | Interleukin 10,Eosinophils (%) | Ferritin,Eosinophils (%) | Antithrombin,Eosinophils (%) | Fibrin (pro) degradation products,albumin | Basophil (%),albumin | eGFR (based on CKD-EPI equation),albumin | Total bilirubin,albumin | Alkaline phosphatase,albumin | Alanine aminotransferase,albumin | Hemoglobin,albumin | Mean hemoglobin content,albumin | Basophil (#),albumin | Neutrophils (%),albumin | Total protein,albumin | Monocytes (%),albumin | Indirect bilirubin,albumin | chlorine,albumin | calcium,albumin | Potassium,albumin | sodium,albumin | Hypersensitive C-reactive protein,albumin | Corrected calcium,albumin | International standardized ratio,albumin | Prothrombin time,albumin | Prothrombin activity,albumin | glucose,albumin | RBC distribution width SD,albumin | RBC distribution width CV,albumin | Average PLT volume,albumin | Platelet compression,albumin | Platelet ratio,albumin | PLT distribution width,albumin | D-D dimer quantification,albumin | Procalcitonin,albumin | Thrombin time,albumin | Activated partial thromboplastin time,albumin | Fibrinogen,albumin | Erythrocyte sedimentation rate,albumin | High-sensitivity cardiac troponin I,albumin | Quantification of hepatitis C antibody,albumin | Treponema pallidum antibody quantification,albumin | Quantification of hepatitis B surface antigen,albumin | HIV antibody quantification,albumin | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),albumin | PH,albumin | Interleukin 6,albumin | Tumor necrosis factor alpha,albumin | Interleukin 8,albumin | Interleukin 1-Beta,albumin | Interleukin 2 receptor,albumin | Interleukin 10,albumin | Ferritin,albumin | Antithrombin,albumin | Fibrin (pro) degradation products,Basophil (%) | eGFR (based on CKD-EPI equation),Basophil (%) | Total bilirubin,Basophil (%) | Alkaline phosphatase,Basophil (%) | Alanine aminotransferase,Basophil (%) | Hemoglobin,Basophil (%) | Mean hemoglobin content,Basophil (%) | Basophil (#),Basophil (%) | Neutrophils (%),Basophil (%) | Total protein,Basophil (%) | Monocytes (%),Basophil (%) | Indirect bilirubin,Basophil (%) | chlorine,Basophil (%) | calcium,Basophil (%) | Potassium,Basophil (%) | sodium,Basophil (%) | Hypersensitive C-reactive protein,Basophil (%) | Corrected calcium,Basophil (%) | International standardized ratio,Basophil (%) | Prothrombin time,Basophil (%) | Prothrombin activity,Basophil (%) | glucose,Basophil (%) | RBC distribution width SD,Basophil (%) | RBC distribution width CV,Basophil (%) | Average PLT volume,Basophil (%) | Platelet compression,Basophil (%) | Platelet ratio,Basophil (%) | PLT distribution width,Basophil (%) | D-D dimer quantification,Basophil (%) | Procalcitonin,Basophil (%) | Thrombin time,Basophil (%) | Activated partial thromboplastin time,Basophil (%) | Fibrinogen,Basophil (%) | Erythrocyte sedimentation rate,Basophil (%) | High-sensitivity cardiac troponin I,Basophil (%) | Quantification of hepatitis C antibody,Basophil (%) | Treponema pallidum antibody quantification,Basophil (%) | Quantification of hepatitis B surface antigen,Basophil (%) | HIV antibody quantification,Basophil (%) | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Basophil (%) | PH,Basophil (%) | Interleukin 6,Basophil (%) | Tumor necrosis factor alpha,Basophil (%) | Interleukin 8,Basophil (%) | Interleukin 1-Beta,Basophil (%) | Interleukin 2 receptor,Basophil (%) | Interleukin 10,Basophil (%) | Ferritin,Basophil (%) | Antithrombin,Basophil (%) | Fibrin (pro) degradation products,eGFR (based on CKD-EPI equation) | Total bilirubin,eGFR (based on CKD-EPI equation) | Alkaline phosphatase,eGFR (based on CKD-EPI equation) | Alanine aminotransferase,eGFR (based on CKD-EPI equation) | Hemoglobin,eGFR (based on CKD-EPI equation) | Mean hemoglobin content,eGFR (based on CKD-EPI equation) | Basophil (#),eGFR (based on CKD-EPI equation) | Neutrophils (%),eGFR (based on CKD-EPI equation) | Total protein,eGFR (based on CKD-EPI equation) | Monocytes (%),eGFR (based on CKD-EPI equation) | Indirect bilirubin,eGFR (based on CKD-EPI equation) | chlorine,eGFR (based on CKD-EPI equation) | calcium,eGFR (based on CKD-EPI equation) | Potassium,eGFR (based on CKD-EPI equation) | sodium,eGFR (based on CKD-EPI equation) | Hypersensitive C-reactive protein,eGFR (based on CKD-EPI equation) | Corrected calcium,eGFR (based on CKD-EPI equation) | International standardized ratio,eGFR (based on CKD-EPI equation) | Prothrombin time,eGFR (based on CKD-EPI equation) | Prothrombin activity,eGFR (based on CKD-EPI equation) | glucose,eGFR (based on CKD-EPI equation) | RBC distribution width SD,eGFR (based on CKD-EPI equation) | RBC distribution width CV,eGFR (based on CKD-EPI equation) | Average PLT volume,eGFR (based on CKD-EPI equation) | Platelet compression,eGFR (based on CKD-EPI equation) | Platelet ratio,eGFR (based on CKD-EPI equation) | PLT distribution width,eGFR (based on CKD-EPI equation) | D-D dimer quantification,eGFR (based on CKD-EPI equation) | Procalcitonin,eGFR (based on CKD-EPI equation) | Thrombin time,eGFR (based on CKD-EPI equation) | Activated partial thromboplastin time,eGFR (based on CKD-EPI equation) | Fibrinogen,eGFR (based on CKD-EPI equation) | Erythrocyte sedimentation rate,eGFR (based on CKD-EPI equation) | High-sensitivity cardiac troponin I,eGFR (based on CKD-EPI equation) | Quantification of hepatitis C antibody,eGFR (based on CKD-EPI equation) | Treponema pallidum antibody quantification,eGFR (based on CKD-EPI equation) | Quantification of hepatitis B surface antigen,eGFR (based on CKD-EPI equation) | HIV antibody quantification,eGFR (based on CKD-EPI equation) | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),eGFR (based on CKD-EPI equation) | PH,eGFR (based on CKD-EPI equation) | Interleukin 6,eGFR (based on CKD-EPI equation) | Tumor necrosis factor alpha,eGFR (based on CKD-EPI equation) | Interleukin 8,eGFR (based on CKD-EPI equation) | Interleukin 1-Beta,eGFR (based on CKD-EPI equation) | Interleukin 2 receptor,eGFR (based on CKD-EPI equation) | Interleukin 10,eGFR (based on CKD-EPI equation) | Ferritin,eGFR (based on CKD-EPI equation) | Antithrombin,eGFR (based on CKD-EPI equation) | Fibrin (pro) degradation products,Total bilirubin | Alkaline phosphatase,Total bilirubin | Alanine aminotransferase,Total bilirubin | Hemoglobin,Total bilirubin | Mean hemoglobin content,Total bilirubin | Basophil (#),Total bilirubin | Neutrophils (%),Total bilirubin | Total protein,Total bilirubin | Monocytes (%),Total bilirubin | Indirect bilirubin,Total bilirubin | chlorine,Total bilirubin | calcium,Total bilirubin | Potassium,Total bilirubin | sodium,Total bilirubin | Hypersensitive C-reactive protein,Total bilirubin | Corrected calcium,Total bilirubin | International standardized ratio,Total bilirubin | Prothrombin time,Total bilirubin | Prothrombin activity,Total bilirubin | glucose,Total bilirubin | RBC distribution width SD,Total bilirubin | RBC distribution width CV,Total bilirubin | Average PLT volume,Total bilirubin | Platelet compression,Total bilirubin | Platelet ratio,Total bilirubin | PLT distribution width,Total bilirubin | D-D dimer quantification,Total bilirubin | Procalcitonin,Total bilirubin | Thrombin time,Total bilirubin | Activated partial thromboplastin time,Total bilirubin | Fibrinogen,Total bilirubin | Erythrocyte sedimentation rate,Total bilirubin | High-sensitivity cardiac troponin I,Total bilirubin | Quantification of hepatitis C antibody,Total bilirubin | Treponema pallidum antibody quantification,Total bilirubin | Quantification of hepatitis B surface antigen,Total bilirubin | HIV antibody quantification,Total bilirubin | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Total bilirubin | PH,Total bilirubin | Interleukin 6,Total bilirubin | Tumor necrosis factor alpha,Total bilirubin | Interleukin 8,Total bilirubin | Interleukin 1-Beta,Total bilirubin | Interleukin 2 receptor,Total bilirubin | Interleukin 10,Total bilirubin | Ferritin,Total bilirubin | Antithrombin,Total bilirubin | Fibrin (pro) degradation products,Alkaline phosphatase | Alanine aminotransferase,Alkaline phosphatase | Hemoglobin,Alkaline phosphatase | Mean hemoglobin content,Alkaline phosphatase | Basophil (#),Alkaline phosphatase | Neutrophils (%),Alkaline phosphatase | Total protein,Alkaline phosphatase | Monocytes (%),Alkaline phosphatase | Indirect bilirubin,Alkaline phosphatase | chlorine,Alkaline phosphatase | calcium,Alkaline phosphatase | Potassium,Alkaline phosphatase | sodium,Alkaline phosphatase | Hypersensitive C-reactive protein,Alkaline phosphatase | Corrected calcium,Alkaline phosphatase | International standardized ratio,Alkaline phosphatase | Prothrombin time,Alkaline phosphatase | Prothrombin activity,Alkaline phosphatase | glucose,Alkaline phosphatase | RBC distribution width SD,Alkaline phosphatase | RBC distribution width CV,Alkaline phosphatase | Average PLT volume,Alkaline phosphatase | Platelet compression,Alkaline phosphatase | Platelet ratio,Alkaline phosphatase | PLT distribution width,Alkaline phosphatase | D-D dimer quantification,Alkaline phosphatase | Procalcitonin,Alkaline phosphatase | Thrombin time,Alkaline phosphatase | Activated partial thromboplastin time,Alkaline phosphatase | Fibrinogen,Alkaline phosphatase | Erythrocyte sedimentation rate,Alkaline phosphatase | High-sensitivity cardiac troponin I,Alkaline phosphatase | Quantification of hepatitis C antibody,Alkaline phosphatase | Treponema pallidum antibody quantification,Alkaline phosphatase | Quantification of hepatitis B surface antigen,Alkaline phosphatase | HIV antibody quantification,Alkaline phosphatase | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Alkaline phosphatase | PH,Alkaline phosphatase | Interleukin 6,Alkaline phosphatase | Tumor necrosis factor alpha,Alkaline phosphatase | Interleukin 8,Alkaline phosphatase | Interleukin 1-Beta,Alkaline phosphatase | Interleukin 2 receptor,Alkaline phosphatase | Interleukin 10,Alkaline phosphatase | Ferritin,Alkaline phosphatase | Antithrombin,Alkaline phosphatase | Fibrin (pro) degradation products,Alanine aminotransferase | Hemoglobin,Alanine aminotransferase | Mean hemoglobin content,Alanine aminotransferase | Basophil (#),Alanine aminotransferase | Neutrophils (%),Alanine aminotransferase | Total protein,Alanine aminotransferase | Monocytes (%),Alanine aminotransferase | Indirect bilirubin,Alanine aminotransferase | chlorine,Alanine aminotransferase | calcium,Alanine aminotransferase | Potassium,Alanine aminotransferase | sodium,Alanine aminotransferase | Hypersensitive C-reactive protein,Alanine aminotransferase | Corrected calcium,Alanine aminotransferase | International standardized ratio,Alanine aminotransferase | Prothrombin time,Alanine aminotransferase | Prothrombin activity,Alanine aminotransferase | glucose,Alanine aminotransferase | RBC distribution width SD,Alanine aminotransferase | RBC distribution width CV,Alanine aminotransferase | Average PLT volume,Alanine aminotransferase | Platelet compression,Alanine aminotransferase | Platelet ratio,Alanine aminotransferase | PLT distribution width,Alanine aminotransferase | D-D dimer quantification,Alanine aminotransferase | Procalcitonin,Alanine aminotransferase | Thrombin time,Alanine aminotransferase | Activated partial thromboplastin time,Alanine aminotransferase | Fibrinogen,Alanine aminotransferase | Erythrocyte sedimentation rate,Alanine aminotransferase | High-sensitivity cardiac troponin I,Alanine aminotransferase | Quantification of hepatitis C antibody,Alanine aminotransferase | Treponema pallidum antibody quantification,Alanine aminotransferase | Quantification of hepatitis B surface antigen,Alanine aminotransferase | HIV antibody quantification,Alanine aminotransferase | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Alanine aminotransferase | PH,Alanine aminotransferase | Interleukin 6,Alanine aminotransferase | Tumor necrosis factor alpha,Alanine aminotransferase | Interleukin 8,Alanine aminotransferase | Interleukin 1-Beta,Alanine aminotransferase | Interleukin 2 receptor,Alanine aminotransferase | Interleukin 10,Alanine aminotransferase | Ferritin,Alanine aminotransferase | Antithrombin,Alanine aminotransferase | Fibrin (pro) degradation products,Hemoglobin | Mean hemoglobin content,Hemoglobin | Basophil (#),Hemoglobin | Neutrophils (%),Hemoglobin | Total protein,Hemoglobin | Monocytes (%),Hemoglobin | Indirect bilirubin,Hemoglobin | chlorine,Hemoglobin | calcium,Hemoglobin | Potassium,Hemoglobin | sodium,Hemoglobin | Hypersensitive C-reactive protein,Hemoglobin | Corrected calcium,Hemoglobin | International standardized ratio,Hemoglobin | Prothrombin time,Hemoglobin | Prothrombin activity,Hemoglobin | glucose,Hemoglobin | RBC distribution width SD,Hemoglobin | RBC distribution width CV,Hemoglobin | Average PLT volume,Hemoglobin | Platelet compression,Hemoglobin | Platelet ratio,Hemoglobin | PLT distribution width,Hemoglobin | D-D dimer quantification,Hemoglobin | Procalcitonin,Hemoglobin | Thrombin time,Hemoglobin | Activated partial thromboplastin time,Hemoglobin | Fibrinogen,Hemoglobin | Erythrocyte sedimentation rate,Hemoglobin | High-sensitivity cardiac troponin I,Hemoglobin | Quantification of hepatitis C antibody,Hemoglobin | Treponema pallidum antibody quantification,Hemoglobin | Quantification of hepatitis B surface antigen,Hemoglobin | HIV antibody quantification,Hemoglobin | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Hemoglobin | PH,Hemoglobin | Interleukin 6,Hemoglobin | Tumor necrosis factor alpha,Hemoglobin | Interleukin 8,Hemoglobin | Interleukin 1-Beta,Hemoglobin | Interleukin 2 receptor,Hemoglobin | Interleukin 10,Hemoglobin | Ferritin,Hemoglobin | Antithrombin,Hemoglobin | Fibrin (pro) degradation products,Mean hemoglobin content | Basophil (#),Mean hemoglobin content | Neutrophils (%),Mean hemoglobin content | Total protein,Mean hemoglobin content | Monocytes (%),Mean hemoglobin content | Indirect bilirubin,Mean hemoglobin content | chlorine,Mean hemoglobin content | calcium,Mean hemoglobin content | Potassium,Mean hemoglobin content | sodium,Mean hemoglobin content | Hypersensitive C-reactive protein,Mean hemoglobin content | Corrected calcium,Mean hemoglobin content | International standardized ratio,Mean hemoglobin content | Prothrombin time,Mean hemoglobin content | Prothrombin activity,Mean hemoglobin content | glucose,Mean hemoglobin content | RBC distribution width SD,Mean hemoglobin content | RBC distribution width CV,Mean hemoglobin content | Average PLT volume,Mean hemoglobin content | Platelet compression,Mean hemoglobin content | Platelet ratio,Mean hemoglobin content | PLT distribution width,Mean hemoglobin content | D-D dimer quantification,Mean hemoglobin content | Procalcitonin,Mean hemoglobin content | Thrombin time,Mean hemoglobin content | Activated partial thromboplastin time,Mean hemoglobin content | Fibrinogen,Mean hemoglobin content | Erythrocyte sedimentation rate,Mean hemoglobin content | High-sensitivity cardiac troponin I,Mean hemoglobin content | Quantification of hepatitis C antibody,Mean hemoglobin content | Treponema pallidum antibody quantification,Mean hemoglobin content | Quantification of hepatitis B surface antigen,Mean hemoglobin content | HIV antibody quantification,Mean hemoglobin content | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Mean hemoglobin content | PH,Mean hemoglobin content | Interleukin 6,Mean hemoglobin content | Tumor necrosis factor alpha,Mean hemoglobin content | Interleukin 8,Mean hemoglobin content | Interleukin 1-Beta,Mean hemoglobin content | Interleukin 2 receptor,Mean hemoglobin content | Interleukin 10,Mean hemoglobin content | Ferritin,Mean hemoglobin content | Antithrombin,Mean hemoglobin content | Fibrin (pro) degradation products,Basophil (#) | Neutrophils (%),Basophil (#) | Total protein,Basophil (#) | Monocytes (%),Basophil (#) | Indirect bilirubin,Basophil (#) | chlorine,Basophil (#) | calcium,Basophil (#) | Potassium,Basophil (#) | sodium,Basophil (#) | Hypersensitive C-reactive protein,Basophil (#) | Corrected calcium,Basophil (#) | International standardized ratio,Basophil (#) | Prothrombin time,Basophil (#) | Prothrombin activity,Basophil (#) | glucose,Basophil (#) | RBC distribution width SD,Basophil (#) | RBC distribution width CV,Basophil (#) | Average PLT volume,Basophil (#) | Platelet compression,Basophil (#) | Platelet ratio,Basophil (#) | PLT distribution width,Basophil (#) | D-D dimer quantification,Basophil (#) | Procalcitonin,Basophil (#) | Thrombin time,Basophil (#) | Activated partial thromboplastin time,Basophil (#) | Fibrinogen,Basophil (#) | Erythrocyte sedimentation rate,Basophil (#) | High-sensitivity cardiac troponin I,Basophil (#) | Quantification of hepatitis C antibody,Basophil (#) | Treponema pallidum antibody quantification,Basophil (#) | Quantification of hepatitis B surface antigen,Basophil (#) | HIV antibody quantification,Basophil (#) | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Basophil (#) | PH,Basophil (#) | Interleukin 6,Basophil (#) | Tumor necrosis factor alpha,Basophil (#) | Interleukin 8,Basophil (#) | Interleukin 1-Beta,Basophil (#) | Interleukin 2 receptor,Basophil (#) | Interleukin 10,Basophil (#) | Ferritin,Basophil (#) | Antithrombin,Basophil (#) | Fibrin (pro) degradation products,Neutrophils (%) | Total protein,Neutrophils (%) | Monocytes (%),Neutrophils (%) | Indirect bilirubin,Neutrophils (%) | chlorine,Neutrophils (%) | calcium,Neutrophils (%) | Potassium,Neutrophils (%) | sodium,Neutrophils (%) | Hypersensitive C-reactive protein,Neutrophils (%) | Corrected calcium,Neutrophils (%) | International standardized ratio,Neutrophils (%) | Prothrombin time,Neutrophils (%) | Prothrombin activity,Neutrophils (%) | glucose,Neutrophils (%) | RBC distribution width SD,Neutrophils (%) | RBC distribution width CV,Neutrophils (%) | Average PLT volume,Neutrophils (%) | Platelet compression,Neutrophils (%) | Platelet ratio,Neutrophils (%) | PLT distribution width,Neutrophils (%) | D-D dimer quantification,Neutrophils (%) | Procalcitonin,Neutrophils (%) | Thrombin time,Neutrophils (%) | Activated partial thromboplastin time,Neutrophils (%) | Fibrinogen,Neutrophils (%) | Erythrocyte sedimentation rate,Neutrophils (%) | High-sensitivity cardiac troponin I,Neutrophils (%) | Quantification of hepatitis C antibody,Neutrophils (%) | Treponema pallidum antibody quantification,Neutrophils (%) | Quantification of hepatitis B surface antigen,Neutrophils (%) | HIV antibody quantification,Neutrophils (%) | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Neutrophils (%) | PH,Neutrophils (%) | Interleukin 6,Neutrophils (%) | Tumor necrosis factor alpha,Neutrophils (%) | Interleukin 8,Neutrophils (%) | Interleukin 1-Beta,Neutrophils (%) | Interleukin 2 receptor,Neutrophils (%) | Interleukin 10,Neutrophils (%) | Ferritin,Neutrophils (%) | Antithrombin,Neutrophils (%) | Fibrin (pro) degradation products,Total protein | Monocytes (%),Total protein | Indirect bilirubin,Total protein | chlorine,Total protein | calcium,Total protein | Potassium,Total protein | sodium,Total protein | Hypersensitive C-reactive protein,Total protein | Corrected calcium,Total protein | International standardized ratio,Total protein | Prothrombin time,Total protein | Prothrombin activity,Total protein | glucose,Total protein | RBC distribution width SD,Total protein | RBC distribution width CV,Total protein | Average PLT volume,Total protein | Platelet compression,Total protein | Platelet ratio,Total protein | PLT distribution width,Total protein | D-D dimer quantification,Total protein | Procalcitonin,Total protein | Thrombin time,Total protein | Activated partial thromboplastin time,Total protein | Fibrinogen,Total protein | Erythrocyte sedimentation rate,Total protein | High-sensitivity cardiac troponin I,Total protein | Quantification of hepatitis C antibody,Total protein | Treponema pallidum antibody quantification,Total protein | Quantification of hepatitis B surface antigen,Total protein | HIV antibody quantification,Total protein | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Total protein | PH,Total protein | Interleukin 6,Total protein | Tumor necrosis factor alpha,Total protein | Interleukin 8,Total protein | Interleukin 1-Beta,Total protein | Interleukin 2 receptor,Total protein | Interleukin 10,Total protein | Ferritin,Total protein | Antithrombin,Total protein | Fibrin (pro) degradation products,Monocytes (%) | Indirect bilirubin,Monocytes (%) | chlorine,Monocytes (%) | calcium,Monocytes (%) | Potassium,Monocytes (%) | sodium,Monocytes (%) | Hypersensitive C-reactive protein,Monocytes (%) | Corrected calcium,Monocytes (%) | International standardized ratio,Monocytes (%) | Prothrombin time,Monocytes (%) | Prothrombin activity,Monocytes (%) | glucose,Monocytes (%) | RBC distribution width SD,Monocytes (%) | RBC distribution width CV,Monocytes (%) | Average PLT volume,Monocytes (%) | Platelet compression,Monocytes (%) | Platelet ratio,Monocytes (%) | PLT distribution width,Monocytes (%) | D-D dimer quantification,Monocytes (%) | Procalcitonin,Monocytes (%) | Thrombin time,Monocytes (%) | Activated partial thromboplastin time,Monocytes (%) | Fibrinogen,Monocytes (%) | Erythrocyte sedimentation rate,Monocytes (%) | High-sensitivity cardiac troponin I,Monocytes (%) | Quantification of hepatitis C antibody,Monocytes (%) | Treponema pallidum antibody quantification,Monocytes (%) | Quantification of hepatitis B surface antigen,Monocytes (%) | HIV antibody quantification,Monocytes (%) | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Monocytes (%) | PH,Monocytes (%) | Interleukin 6,Monocytes (%) | Tumor necrosis factor alpha,Monocytes (%) | Interleukin 8,Monocytes (%) | Interleukin 1-Beta,Monocytes (%) | Interleukin 2 receptor,Monocytes (%) | Interleukin 10,Monocytes (%) | Ferritin,Monocytes (%) | Antithrombin,Monocytes (%) | Fibrin (pro) degradation products,Indirect bilirubin | chlorine,Indirect bilirubin | calcium,Indirect bilirubin | Potassium,Indirect bilirubin | sodium,Indirect bilirubin | Hypersensitive C-reactive protein,Indirect bilirubin | Corrected calcium,Indirect bilirubin | International standardized ratio,Indirect bilirubin | Prothrombin time,Indirect bilirubin | Prothrombin activity,Indirect bilirubin | glucose,Indirect bilirubin | RBC distribution width SD,Indirect bilirubin | RBC distribution width CV,Indirect bilirubin | Average PLT volume,Indirect bilirubin | Platelet compression,Indirect bilirubin | Platelet ratio,Indirect bilirubin | PLT distribution width,Indirect bilirubin | D-D dimer quantification,Indirect bilirubin | Procalcitonin,Indirect bilirubin | Thrombin time,Indirect bilirubin | Activated partial thromboplastin time,Indirect bilirubin | Fibrinogen,Indirect bilirubin | Erythrocyte sedimentation rate,Indirect bilirubin | High-sensitivity cardiac troponin I,Indirect bilirubin | Quantification of hepatitis C antibody,Indirect bilirubin | Treponema pallidum antibody quantification,Indirect bilirubin | Quantification of hepatitis B surface antigen,Indirect bilirubin | HIV antibody quantification,Indirect bilirubin | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Indirect bilirubin | PH,Indirect bilirubin | Interleukin 6,Indirect bilirubin | Tumor necrosis factor alpha,Indirect bilirubin | Interleukin 8,Indirect bilirubin | Interleukin 1-Beta,Indirect bilirubin | Interleukin 2 receptor,Indirect bilirubin | Interleukin 10,Indirect bilirubin | Ferritin,Indirect bilirubin | Antithrombin,Indirect bilirubin | Fibrin (pro) degradation products,chlorine | calcium,chlorine | Potassium,chlorine | sodium,chlorine | Hypersensitive C-reactive protein,chlorine | Corrected calcium,chlorine | International standardized ratio,chlorine | Prothrombin time,chlorine | Prothrombin activity,chlorine | glucose,chlorine | RBC distribution width SD,chlorine | RBC distribution width CV,chlorine | Average PLT volume,chlorine | Platelet compression,chlorine | Platelet ratio,chlorine | PLT distribution width,chlorine | D-D dimer quantification,chlorine | Procalcitonin,chlorine | Thrombin time,chlorine | Activated partial thromboplastin time,chlorine | Fibrinogen,chlorine | Erythrocyte sedimentation rate,chlorine | High-sensitivity cardiac troponin I,chlorine | Quantification of hepatitis C antibody,chlorine | Treponema pallidum antibody quantification,chlorine | Quantification of hepatitis B surface antigen,chlorine | HIV antibody quantification,chlorine | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),chlorine | PH,chlorine | Interleukin 6,chlorine | Tumor necrosis factor alpha,chlorine | Interleukin 8,chlorine | Interleukin 1-Beta,chlorine | Interleukin 2 receptor,chlorine | Interleukin 10,chlorine | Ferritin,chlorine | Antithrombin,chlorine | Fibrin (pro) degradation products,calcium | Potassium,calcium | sodium,calcium | Hypersensitive C-reactive protein,calcium | Corrected calcium,calcium | International standardized ratio,calcium | Prothrombin time,calcium | Prothrombin activity,calcium | glucose,calcium | RBC distribution width SD,calcium | RBC distribution width CV,calcium | Average PLT volume,calcium | Platelet compression,calcium | Platelet ratio,calcium | PLT distribution width,calcium | D-D dimer quantification,calcium | Procalcitonin,calcium | Thrombin time,calcium | Activated partial thromboplastin time,calcium | Fibrinogen,calcium | Erythrocyte sedimentation rate,calcium | High-sensitivity cardiac troponin I,calcium | Quantification of hepatitis C antibody,calcium | Treponema pallidum antibody quantification,calcium | Quantification of hepatitis B surface antigen,calcium | HIV antibody quantification,calcium | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),calcium | PH,calcium | Interleukin 6,calcium | Tumor necrosis factor alpha,calcium | Interleukin 8,calcium | Interleukin 1-Beta,calcium | Interleukin 2 receptor,calcium | Interleukin 10,calcium | Ferritin,calcium | Antithrombin,calcium | Fibrin (pro) degradation products,Potassium | sodium,Potassium | Hypersensitive C-reactive protein,Potassium | Corrected calcium,Potassium | International standardized ratio,Potassium | Prothrombin time,Potassium | Prothrombin activity,Potassium | glucose,Potassium | RBC distribution width SD,Potassium | RBC distribution width CV,Potassium | Average PLT volume,Potassium | Platelet compression,Potassium | Platelet ratio,Potassium | PLT distribution width,Potassium | D-D dimer quantification,Potassium | Procalcitonin,Potassium | Thrombin time,Potassium | Activated partial thromboplastin time,Potassium | Fibrinogen,Potassium | Erythrocyte sedimentation rate,Potassium | High-sensitivity cardiac troponin I,Potassium | Quantification of hepatitis C antibody,Potassium | Treponema pallidum antibody quantification,Potassium | Quantification of hepatitis B surface antigen,Potassium | HIV antibody quantification,Potassium | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Potassium | PH,Potassium | Interleukin 6,Potassium | Tumor necrosis factor alpha,Potassium | Interleukin 8,Potassium | Interleukin 1-Beta,Potassium | Interleukin 2 receptor,Potassium | Interleukin 10,Potassium | Ferritin,Potassium | Antithrombin,Potassium | Fibrin (pro) degradation products,sodium | Hypersensitive C-reactive protein,sodium | Corrected calcium,sodium | International standardized ratio,sodium | Prothrombin time,sodium | Prothrombin activity,sodium | glucose,sodium | RBC distribution width SD,sodium | RBC distribution width CV,sodium | Average PLT volume,sodium | Platelet compression,sodium | Platelet ratio,sodium | PLT distribution width,sodium | D-D dimer quantification,sodium | Procalcitonin,sodium | Thrombin time,sodium | Activated partial thromboplastin time,sodium | Fibrinogen,sodium | Erythrocyte sedimentation rate,sodium | High-sensitivity cardiac troponin I,sodium | Quantification of hepatitis C antibody,sodium | Treponema pallidum antibody quantification,sodium | Quantification of hepatitis B surface antigen,sodium | HIV antibody quantification,sodium | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),sodium | PH,sodium | Interleukin 6,sodium | Tumor necrosis factor alpha,sodium | Interleukin 8,sodium | Interleukin 1-Beta,sodium | Interleukin 2 receptor,sodium | Interleukin 10,sodium | Ferritin,sodium | Antithrombin,sodium | Fibrin (pro) degradation products,Hypersensitive C-reactive protein | Corrected calcium,Hypersensitive C-reactive protein | International standardized ratio,Hypersensitive C-reactive protein | Prothrombin time,Hypersensitive C-reactive protein | Prothrombin activity,Hypersensitive C-reactive protein | glucose,Hypersensitive C-reactive protein | RBC distribution width SD,Hypersensitive C-reactive protein | RBC distribution width CV,Hypersensitive C-reactive protein | Average PLT volume,Hypersensitive C-reactive protein | Platelet compression,Hypersensitive C-reactive protein | Platelet ratio,Hypersensitive C-reactive protein | PLT distribution width,Hypersensitive C-reactive protein | D-D dimer quantification,Hypersensitive C-reactive protein | Procalcitonin,Hypersensitive C-reactive protein | Thrombin time,Hypersensitive C-reactive protein | Activated partial thromboplastin time,Hypersensitive C-reactive protein | Fibrinogen,Hypersensitive C-reactive protein | Erythrocyte sedimentation rate,Hypersensitive C-reactive protein | High-sensitivity cardiac troponin I,Hypersensitive C-reactive protein | Quantification of hepatitis C antibody,Hypersensitive C-reactive protein | Treponema pallidum antibody quantification,Hypersensitive C-reactive protein | Quantification of hepatitis B surface antigen,Hypersensitive C-reactive protein | HIV antibody quantification,Hypersensitive C-reactive protein | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Hypersensitive C-reactive protein | PH,Hypersensitive C-reactive protein | Interleukin 6,Hypersensitive C-reactive protein | Tumor necrosis factor alpha,Hypersensitive C-reactive protein | Interleukin 8,Hypersensitive C-reactive protein | Interleukin 1-Beta,Hypersensitive C-reactive protein | Interleukin 2 receptor,Hypersensitive C-reactive protein | Interleukin 10,Hypersensitive C-reactive protein | Ferritin,Hypersensitive C-reactive protein | Antithrombin,Hypersensitive C-reactive protein | Fibrin (pro) degradation products,Corrected calcium | International standardized ratio,Corrected calcium | Prothrombin time,Corrected calcium | Prothrombin activity,Corrected calcium | glucose,Corrected calcium | RBC distribution width SD,Corrected calcium | RBC distribution width CV,Corrected calcium | Average PLT volume,Corrected calcium | Platelet compression,Corrected calcium | Platelet ratio,Corrected calcium | PLT distribution width,Corrected calcium | D-D dimer quantification,Corrected calcium | Procalcitonin,Corrected calcium | Thrombin time,Corrected calcium | Activated partial thromboplastin time,Corrected calcium | Fibrinogen,Corrected calcium | Erythrocyte sedimentation rate,Corrected calcium | High-sensitivity cardiac troponin I,Corrected calcium | Quantification of hepatitis C antibody,Corrected calcium | Treponema pallidum antibody quantification,Corrected calcium | Quantification of hepatitis B surface antigen,Corrected calcium | HIV antibody quantification,Corrected calcium | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Corrected calcium | PH,Corrected calcium | Interleukin 6,Corrected calcium | Tumor necrosis factor alpha,Corrected calcium | Interleukin 8,Corrected calcium | Interleukin 1-Beta,Corrected calcium | Interleukin 2 receptor,Corrected calcium | Interleukin 10,Corrected calcium | Ferritin,Corrected calcium | Antithrombin,Corrected calcium | Fibrin (pro) degradation products,International standardized ratio | Prothrombin time,International standardized ratio | Prothrombin activity,International standardized ratio | glucose,International standardized ratio | RBC distribution width SD,International standardized ratio | RBC distribution width CV,International standardized ratio | Average PLT volume,International standardized ratio | Platelet compression,International standardized ratio | Platelet ratio,International standardized ratio | PLT distribution width,International standardized ratio | D-D dimer quantification,International standardized ratio | Procalcitonin,International standardized ratio | Thrombin time,International standardized ratio | Activated partial thromboplastin time,International standardized ratio | Fibrinogen,International standardized ratio | Erythrocyte sedimentation rate,International standardized ratio | High-sensitivity cardiac troponin I,International standardized ratio | Quantification of hepatitis C antibody,International standardized ratio | Treponema pallidum antibody quantification,International standardized ratio | Quantification of hepatitis B surface antigen,International standardized ratio | HIV antibody quantification,International standardized ratio | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),International standardized ratio | PH,International standardized ratio | Interleukin 6,International standardized ratio | Tumor necrosis factor alpha,International standardized ratio | Interleukin 8,International standardized ratio | Interleukin 1-Beta,International standardized ratio | Interleukin 2 receptor,International standardized ratio | Interleukin 10,International standardized ratio | Ferritin,International standardized ratio | Antithrombin,International standardized ratio | Fibrin (pro) degradation products,Prothrombin time | Prothrombin activity,Prothrombin time | glucose,Prothrombin time | RBC distribution width SD,Prothrombin time | RBC distribution width CV,Prothrombin time | Average PLT volume,Prothrombin time | Platelet compression,Prothrombin time | Platelet ratio,Prothrombin time | PLT distribution width,Prothrombin time | D-D dimer quantification,Prothrombin time | Procalcitonin,Prothrombin time | Thrombin time,Prothrombin time | Activated partial thromboplastin time,Prothrombin time | Fibrinogen,Prothrombin time | Erythrocyte sedimentation rate,Prothrombin time | High-sensitivity cardiac troponin I,Prothrombin time | Quantification of hepatitis C antibody,Prothrombin time | Treponema pallidum antibody quantification,Prothrombin time | Quantification of hepatitis B surface antigen,Prothrombin time | HIV antibody quantification,Prothrombin time | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Prothrombin time | PH,Prothrombin time | Interleukin 6,Prothrombin time | Tumor necrosis factor alpha,Prothrombin time | Interleukin 8,Prothrombin time | Interleukin 1-Beta,Prothrombin time | Interleukin 2 receptor,Prothrombin time | Interleukin 10,Prothrombin time | Ferritin,Prothrombin time | Antithrombin,Prothrombin time | Fibrin (pro) degradation products,Prothrombin activity | glucose,Prothrombin activity | RBC distribution width SD,Prothrombin activity | RBC distribution width CV,Prothrombin activity | Average PLT volume,Prothrombin activity | Platelet compression,Prothrombin activity | Platelet ratio,Prothrombin activity | PLT distribution width,Prothrombin activity | D-D dimer quantification,Prothrombin activity | Procalcitonin,Prothrombin activity | Thrombin time,Prothrombin activity | Activated partial thromboplastin time,Prothrombin activity | Fibrinogen,Prothrombin activity | Erythrocyte sedimentation rate,Prothrombin activity | High-sensitivity cardiac troponin I,Prothrombin activity | Quantification of hepatitis C antibody,Prothrombin activity | Treponema pallidum antibody quantification,Prothrombin activity | Quantification of hepatitis B surface antigen,Prothrombin activity | HIV antibody quantification,Prothrombin activity | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Prothrombin activity | PH,Prothrombin activity | Interleukin 6,Prothrombin activity | Tumor necrosis factor alpha,Prothrombin activity | Interleukin 8,Prothrombin activity | Interleukin 1-Beta,Prothrombin activity | Interleukin 2 receptor,Prothrombin activity | Interleukin 10,Prothrombin activity | Ferritin,Prothrombin activity | Antithrombin,Prothrombin activity | Fibrin (pro) degradation products,glucose | RBC distribution width SD,glucose | RBC distribution width CV,glucose | Average PLT volume,glucose | Platelet compression,glucose | Platelet ratio,glucose | PLT distribution width,glucose | D-D dimer quantification,glucose | Procalcitonin,glucose | Thrombin time,glucose | Activated partial thromboplastin time,glucose | Fibrinogen,glucose | Erythrocyte sedimentation rate,glucose | High-sensitivity cardiac troponin I,glucose | Quantification of hepatitis C antibody,glucose | Treponema pallidum antibody quantification,glucose | Quantification of hepatitis B surface antigen,glucose | HIV antibody quantification,glucose | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),glucose | PH,glucose | Interleukin 6,glucose | Tumor necrosis factor alpha,glucose | Interleukin 8,glucose | Interleukin 1-Beta,glucose | Interleukin 2 receptor,glucose | Interleukin 10,glucose | Ferritin,glucose | Antithrombin,glucose | Fibrin (pro) degradation products,RBC distribution width SD | RBC distribution width CV,RBC distribution width SD | Average PLT volume,RBC distribution width SD | Platelet compression,RBC distribution width SD | Platelet ratio,RBC distribution width SD | PLT distribution width,RBC distribution width SD | D-D dimer quantification,RBC distribution width SD | Procalcitonin,RBC distribution width SD | Thrombin time,RBC distribution width SD | Activated partial thromboplastin time,RBC distribution width SD | Fibrinogen,RBC distribution width SD | Erythrocyte sedimentation rate,RBC distribution width SD | High-sensitivity cardiac troponin I,RBC distribution width SD | Quantification of hepatitis C antibody,RBC distribution width SD | Treponema pallidum antibody quantification,RBC distribution width SD | Quantification of hepatitis B surface antigen,RBC distribution width SD | HIV antibody quantification,RBC distribution width SD | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),RBC distribution width SD | PH,RBC distribution width SD | Interleukin 6,RBC distribution width SD | Tumor necrosis factor alpha,RBC distribution width SD | Interleukin 8,RBC distribution width SD | Interleukin 1-Beta,RBC distribution width SD | Interleukin 2 receptor,RBC distribution width SD | Interleukin 10,RBC distribution width SD | Ferritin,RBC distribution width SD | Antithrombin,RBC distribution width SD | Fibrin (pro) degradation products,RBC distribution width CV | Average PLT volume,RBC distribution width CV | Platelet compression,RBC distribution width CV | Platelet ratio,RBC distribution width CV | PLT distribution width,RBC distribution width CV | D-D dimer quantification,RBC distribution width CV | Procalcitonin,RBC distribution width CV | Thrombin time,RBC distribution width CV | Activated partial thromboplastin time,RBC distribution width CV | Fibrinogen,RBC distribution width CV | Erythrocyte sedimentation rate,RBC distribution width CV | High-sensitivity cardiac troponin I,RBC distribution width CV | Quantification of hepatitis C antibody,RBC distribution width CV | Treponema pallidum antibody quantification,RBC distribution width CV | Quantification of hepatitis B surface antigen,RBC distribution width CV | HIV antibody quantification,RBC distribution width CV | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),RBC distribution width CV | PH,RBC distribution width CV | Interleukin 6,RBC distribution width CV | Tumor necrosis factor alpha,RBC distribution width CV | Interleukin 8,RBC distribution width CV | Interleukin 1-Beta,RBC distribution width CV | Interleukin 2 receptor,RBC distribution width CV | Interleukin 10,RBC distribution width CV | Ferritin,RBC distribution width CV | Antithrombin,RBC distribution width CV | Fibrin (pro) degradation products,Average PLT volume | Platelet compression,Average PLT volume | Platelet ratio,Average PLT volume | PLT distribution width,Average PLT volume | D-D dimer quantification,Average PLT volume | Procalcitonin,Average PLT volume | Thrombin time,Average PLT volume | Activated partial thromboplastin time,Average PLT volume | Fibrinogen,Average PLT volume | Erythrocyte sedimentation rate,Average PLT volume | High-sensitivity cardiac troponin I,Average PLT volume | Quantification of hepatitis C antibody,Average PLT volume | Treponema pallidum antibody quantification,Average PLT volume | Quantification of hepatitis B surface antigen,Average PLT volume | HIV antibody quantification,Average PLT volume | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Average PLT volume | PH,Average PLT volume | Interleukin 6,Average PLT volume | Tumor necrosis factor alpha,Average PLT volume | Interleukin 8,Average PLT volume | Interleukin 1-Beta,Average PLT volume | Interleukin 2 receptor,Average PLT volume | Interleukin 10,Average PLT volume | Ferritin,Average PLT volume | Antithrombin,Average PLT volume | Fibrin (pro) degradation products,Platelet compression | Platelet ratio,Platelet compression | PLT distribution width,Platelet compression | D-D dimer quantification,Platelet compression | Procalcitonin,Platelet compression | Thrombin time,Platelet compression | Activated partial thromboplastin time,Platelet compression | Fibrinogen,Platelet compression | Erythrocyte sedimentation rate,Platelet compression | High-sensitivity cardiac troponin I,Platelet compression | Quantification of hepatitis C antibody,Platelet compression | Treponema pallidum antibody quantification,Platelet compression | Quantification of hepatitis B surface antigen,Platelet compression | HIV antibody quantification,Platelet compression | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Platelet compression | PH,Platelet compression | Interleukin 6,Platelet compression | Tumor necrosis factor alpha,Platelet compression | Interleukin 8,Platelet compression | Interleukin 1-Beta,Platelet compression | Interleukin 2 receptor,Platelet compression | Interleukin 10,Platelet compression | Ferritin,Platelet compression | Antithrombin,Platelet compression | Fibrin (pro) degradation products,Platelet ratio | PLT distribution width,Platelet ratio | D-D dimer quantification,Platelet ratio | Procalcitonin,Platelet ratio | Thrombin time,Platelet ratio | Activated partial thromboplastin time,Platelet ratio | Fibrinogen,Platelet ratio | Erythrocyte sedimentation rate,Platelet ratio | High-sensitivity cardiac troponin I,Platelet ratio | Quantification of hepatitis C antibody,Platelet ratio | Treponema pallidum antibody quantification,Platelet ratio | Quantification of hepatitis B surface antigen,Platelet ratio | HIV antibody quantification,Platelet ratio | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Platelet ratio | PH,Platelet ratio | Interleukin 6,Platelet ratio | Tumor necrosis factor alpha,Platelet ratio | Interleukin 8,Platelet ratio | Interleukin 1-Beta,Platelet ratio | Interleukin 2 receptor,Platelet ratio | Interleukin 10,Platelet ratio | Ferritin,Platelet ratio | Antithrombin,Platelet ratio | Fibrin (pro) degradation products,PLT distribution width | D-D dimer quantification,PLT distribution width | Procalcitonin,PLT distribution width | Thrombin time,PLT distribution width | Activated partial thromboplastin time,PLT distribution width | Fibrinogen,PLT distribution width | Erythrocyte sedimentation rate,PLT distribution width | High-sensitivity cardiac troponin I,PLT distribution width | Quantification of hepatitis C antibody,PLT distribution width | Treponema pallidum antibody quantification,PLT distribution width | Quantification of hepatitis B surface antigen,PLT distribution width | HIV antibody quantification,PLT distribution width | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),PLT distribution width | PH,PLT distribution width | Interleukin 6,PLT distribution width | Tumor necrosis factor alpha,PLT distribution width | Interleukin 8,PLT distribution width | Interleukin 1-Beta,PLT distribution width | Interleukin 2 receptor,PLT distribution width | Interleukin 10,PLT distribution width | Ferritin,PLT distribution width | Antithrombin,PLT distribution width | Fibrin (pro) degradation products,D-D dimer quantification | Procalcitonin,D-D dimer quantification | Thrombin time,D-D dimer quantification | Activated partial thromboplastin time,D-D dimer quantification | Fibrinogen,D-D dimer quantification | Erythrocyte sedimentation rate,D-D dimer quantification | High-sensitivity cardiac troponin I,D-D dimer quantification | Quantification of hepatitis C antibody,D-D dimer quantification | Treponema pallidum antibody quantification,D-D dimer quantification | Quantification of hepatitis B surface antigen,D-D dimer quantification | HIV antibody quantification,D-D dimer quantification | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),D-D dimer quantification | PH,D-D dimer quantification | Interleukin 6,D-D dimer quantification | Tumor necrosis factor alpha,D-D dimer quantification | Interleukin 8,D-D dimer quantification | Interleukin 1-Beta,D-D dimer quantification | Interleukin 2 receptor,D-D dimer quantification | Interleukin 10,D-D dimer quantification | Ferritin,D-D dimer quantification | Antithrombin,D-D dimer quantification | Fibrin (pro) degradation products,Procalcitonin | Thrombin time,Procalcitonin | Activated partial thromboplastin time,Procalcitonin | Fibrinogen,Procalcitonin | Erythrocyte sedimentation rate,Procalcitonin | High-sensitivity cardiac troponin I,Procalcitonin | Quantification of hepatitis C antibody,Procalcitonin | Treponema pallidum antibody quantification,Procalcitonin | Quantification of hepatitis B surface antigen,Procalcitonin | HIV antibody quantification,Procalcitonin | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Procalcitonin | PH,Procalcitonin | Interleukin 6,Procalcitonin | Tumor necrosis factor alpha,Procalcitonin | Interleukin 8,Procalcitonin | Interleukin 1-Beta,Procalcitonin | Interleukin 2 receptor,Procalcitonin | Interleukin 10,Procalcitonin | Ferritin,Procalcitonin | Antithrombin,Procalcitonin | Fibrin (pro) degradation products,Thrombin time | Activated partial thromboplastin time,Thrombin time | Fibrinogen,Thrombin time | Erythrocyte sedimentation rate,Thrombin time | High-sensitivity cardiac troponin I,Thrombin time | Quantification of hepatitis C antibody,Thrombin time | Treponema pallidum antibody quantification,Thrombin time | Quantification of hepatitis B surface antigen,Thrombin time | HIV antibody quantification,Thrombin time | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Thrombin time | PH,Thrombin time | Interleukin 6,Thrombin time | Tumor necrosis factor alpha,Thrombin time | Interleukin 8,Thrombin time | Interleukin 1-Beta,Thrombin time | Interleukin 2 receptor,Thrombin time | Interleukin 10,Thrombin time | Ferritin,Thrombin time | Antithrombin,Thrombin time | Fibrin (pro) degradation products,Activated partial thromboplastin time | Fibrinogen,Activated partial thromboplastin time | Erythrocyte sedimentation rate,Activated partial thromboplastin time | High-sensitivity cardiac troponin I,Activated partial thromboplastin time | Quantification of hepatitis C antibody,Activated partial thromboplastin time | Treponema pallidum antibody quantification,Activated partial thromboplastin time | Quantification of hepatitis B surface antigen,Activated partial thromboplastin time | HIV antibody quantification,Activated partial thromboplastin time | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Activated partial thromboplastin time | PH,Activated partial thromboplastin time | Interleukin 6,Activated partial thromboplastin time | Tumor necrosis factor alpha,Activated partial thromboplastin time | Interleukin 8,Activated partial thromboplastin time | Interleukin 1-Beta,Activated partial thromboplastin time | Interleukin 2 receptor,Activated partial thromboplastin time | Interleukin 10,Activated partial thromboplastin time | Ferritin,Activated partial thromboplastin time | Antithrombin,Activated partial thromboplastin time | Fibrin (pro) degradation products,Fibrinogen | Erythrocyte sedimentation rate,Fibrinogen | High-sensitivity cardiac troponin I,Fibrinogen | Quantification of hepatitis C antibody,Fibrinogen | Treponema pallidum antibody quantification,Fibrinogen | Quantification of hepatitis B surface antigen,Fibrinogen | HIV antibody quantification,Fibrinogen | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Fibrinogen | PH,Fibrinogen | Interleukin 6,Fibrinogen | Tumor necrosis factor alpha,Fibrinogen | Interleukin 8,Fibrinogen | Interleukin 1-Beta,Fibrinogen | Interleukin 2 receptor,Fibrinogen | Interleukin 10,Fibrinogen | Ferritin,Fibrinogen | Antithrombin,Fibrinogen | Fibrin (pro) degradation products,Erythrocyte sedimentation rate | High-sensitivity cardiac troponin I,Erythrocyte sedimentation rate | Quantification of hepatitis C antibody,Erythrocyte sedimentation rate | Treponema pallidum antibody quantification,Erythrocyte sedimentation rate | Quantification of hepatitis B surface antigen,Erythrocyte sedimentation rate | HIV antibody quantification,Erythrocyte sedimentation rate | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Erythrocyte sedimentation rate | PH,Erythrocyte sedimentation rate | Interleukin 6,Erythrocyte sedimentation rate | Tumor necrosis factor alpha,Erythrocyte sedimentation rate | Interleukin 8,Erythrocyte sedimentation rate | Interleukin 1-Beta,Erythrocyte sedimentation rate | Interleukin 2 receptor,Erythrocyte sedimentation rate | Interleukin 10,Erythrocyte sedimentation rate | Ferritin,Erythrocyte sedimentation rate | Antithrombin,Erythrocyte sedimentation rate | Fibrin (pro) degradation products,High-sensitivity cardiac troponin I | Quantification of hepatitis C antibody,High-sensitivity cardiac troponin I | Treponema pallidum antibody quantification,High-sensitivity cardiac troponin I | Quantification of hepatitis B surface antigen,High-sensitivity cardiac troponin I | HIV antibody quantification,High-sensitivity cardiac troponin I | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),High-sensitivity cardiac troponin I | PH,High-sensitivity cardiac troponin I | Interleukin 6,High-sensitivity cardiac troponin I | Tumor necrosis factor alpha,High-sensitivity cardiac troponin I | Interleukin 8,High-sensitivity cardiac troponin I | Interleukin 1-Beta,High-sensitivity cardiac troponin I | Interleukin 2 receptor,High-sensitivity cardiac troponin I | Interleukin 10,High-sensitivity cardiac troponin I | Ferritin,High-sensitivity cardiac troponin I | Antithrombin,High-sensitivity cardiac troponin I | Fibrin (pro) degradation products,Quantification of hepatitis C antibody | Treponema pallidum antibody quantification,Quantification of hepatitis C antibody | Quantification of hepatitis B surface antigen,Quantification of hepatitis C antibody | HIV antibody quantification,Quantification of hepatitis C antibody | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Quantification of hepatitis C antibody | PH,Quantification of hepatitis C antibody | Interleukin 6,Quantification of hepatitis C antibody | Tumor necrosis factor alpha,Quantification of hepatitis C antibody | Interleukin 8,Quantification of hepatitis C antibody | Interleukin 1-Beta,Quantification of hepatitis C antibody | Interleukin 2 receptor,Quantification of hepatitis C antibody | Interleukin 10,Quantification of hepatitis C antibody | Ferritin,Quantification of hepatitis C antibody | Antithrombin,Quantification of hepatitis C antibody | Fibrin (pro) degradation products,Treponema pallidum antibody quantification | Quantification of hepatitis B surface antigen,Treponema pallidum antibody quantification | HIV antibody quantification,Treponema pallidum antibody quantification | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Treponema pallidum antibody quantification | PH,Treponema pallidum antibody quantification | Interleukin 6,Treponema pallidum antibody quantification | Tumor necrosis factor alpha,Treponema pallidum antibody quantification | Interleukin 8,Treponema pallidum antibody quantification | Interleukin 1-Beta,Treponema pallidum antibody quantification | Interleukin 2 receptor,Treponema pallidum antibody quantification | Interleukin 10,Treponema pallidum antibody quantification | Ferritin,Treponema pallidum antibody quantification | Antithrombin,Treponema pallidum antibody quantification | Fibrin (pro) degradation products,Quantification of hepatitis B surface antigen | HIV antibody quantification,Quantification of hepatitis B surface antigen | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),Quantification of hepatitis B surface antigen | PH,Quantification of hepatitis B surface antigen | Interleukin 6,Quantification of hepatitis B surface antigen | Tumor necrosis factor alpha,Quantification of hepatitis B surface antigen | Interleukin 8,Quantification of hepatitis B surface antigen | Interleukin 1-Beta,Quantification of hepatitis B surface antigen | Interleukin 2 receptor,Quantification of hepatitis B surface antigen | Interleukin 10,Quantification of hepatitis B surface antigen | Ferritin,Quantification of hepatitis B surface antigen | Antithrombin,Quantification of hepatitis B surface antigen | Fibrin (pro) degradation products,HIV antibody quantification | Amino-terminal brain natriuretic peptide precursor (NT-proBNP),HIV antibody quantification | PH,HIV antibody quantification | Interleukin 6,HIV antibody quantification | Tumor necrosis factor alpha,HIV antibody quantification | Interleukin 8,HIV antibody quantification | Interleukin 1-Beta,HIV antibody quantification | Interleukin 2 receptor,HIV antibody quantification | Interleukin 10,HIV antibody quantification | Ferritin,HIV antibody quantification | Antithrombin,HIV antibody quantification | Fibrin (pro) degradation products,Amino-terminal brain natriuretic peptide precursor (NT-proBNP) | PH,Amino-terminal brain natriuretic peptide precursor (NT-proBNP) | Interleukin 6,Amino-terminal brain natriuretic peptide precursor (NT-proBNP) | Tumor necrosis factor alpha,Amino-terminal brain natriuretic peptide precursor (NT-proBNP) | Interleukin 8,Amino-terminal brain natriuretic peptide precursor (NT-proBNP) | Interleukin 1-Beta,Amino-terminal brain natriuretic peptide precursor (NT-proBNP) | Interleukin 2 receptor,Amino-terminal brain natriuretic peptide precursor (NT-proBNP) | Interleukin 10,Amino-terminal brain natriuretic peptide precursor (NT-proBNP) | Ferritin,Amino-terminal brain natriuretic peptide precursor (NT-proBNP) | Antithrombin,Amino-terminal brain natriuretic peptide precursor (NT-proBNP) | Fibrin (pro) degradation products,PH | Interleukin 6,PH | Tumor necrosis factor alpha,PH | Interleukin 8,PH | Interleukin 1-Beta,PH | Interleukin 2 receptor,PH | Interleukin 10,PH | Ferritin,PH | Antithrombin,PH | Fibrin (pro) degradation products,Interleukin 6 | Tumor necrosis factor alpha,Interleukin 6 | Interleukin 8,Interleukin 6 | Interleukin 1-Beta,Interleukin 6 | Interleukin 2 receptor,Interleukin 6 | Interleukin 10,Interleukin 6 | Ferritin,Interleukin 6 | Antithrombin,Interleukin 6 | Fibrin (pro) degradation products,Tumor necrosis factor alpha | Interleukin 8,Tumor necrosis factor alpha | Interleukin 1-Beta,Tumor necrosis factor alpha | Interleukin 2 receptor,Tumor necrosis factor alpha | Interleukin 10,Tumor necrosis factor alpha | Ferritin,Tumor necrosis factor alpha | Antithrombin,Tumor necrosis factor alpha | Fibrin (pro) degradation products,Interleukin 8 | Interleukin 1-Beta,Interleukin 8 | Interleukin 2 receptor,Interleukin 8 | Interleukin 10,Interleukin 8 | Ferritin,Interleukin 8 | Antithrombin,Interleukin 8 | Fibrin (pro) degradation products,Interleukin 1-Beta | Interleukin 2 receptor,Interleukin 1-Beta | Interleukin 10,Interleukin 1-Beta | Ferritin,Interleukin 1-Beta | Antithrombin,Interleukin 1-Beta | Fibrin (pro) degradation products,Interleukin 2 receptor | Interleukin 10,Interleukin 2 receptor | Ferritin,Interleukin 2 receptor | Antithrombin,Interleukin 2 receptor | Fibrin (pro) degradation products,Interleukin 10 | Ferritin,Interleukin 10 | Antithrombin,Interleukin 10 | Fibrin (pro) degradation products,Ferritin | Antithrombin,Ferritin | Fibrin (pro) degradation products,Antithrombin | Fibrin (pro) degradation products
